The	O
murine	B-DNA
IL-2	I-DNA
promoter	I-DNA
contains	O
distal	B-DNA
regulatory	I-DNA
elements	I-DNA
responsive	O
to	O
the	O
Ah	B-protein
receptor	I-protein
,	O
a	O
member	O
of	O
the	O
evolutionarily	O
conserved	O
bHLH-PAS	B-protein
transcription	I-protein
factor	I-protein
family	I-protein
.	O

Signaling	O
through	O
the	O
TCR	B-protein
and	O
costimulatory	O
signals	O
primarily	O
control	O
transcription	O
of	O
the	O
IL-2	B-DNA
gene	I-DNA
in	O
naive	B-cell_type
T	I-cell_type
cells	I-cell_type
.	O

The	O
minimal	B-DNA
promoter	I-DNA
necessary	O
for	O
this	O
expression	O
lies	O
proximal	O
,	O
between	O
-300	O
and	O
the	O
transcription	B-DNA
start	I-DNA
site	I-DNA
.	O

We	O
had	O
previously	O
shown	O
that	O
activation	O
of	O
the	O
arylhydrocarbon	B-protein
receptor	I-protein
(	O
AHR	B-protein
)	O
,	O
a	O
member	O
of	O
the	O
bHLH-PAS	B-protein
family	I-protein
of	I-protein
transcription	I-protein
factors	I-protein
,	O
leads	O
to	O
increased	O
mRNA	O
expression	O
of	O
IL-2	B-RNA
in	O
murine	B-cell_type
fetal	I-cell_type
thymocytes	I-cell_type
.	O

The	O
AHR	B-protein
is	O
abundant	O
in	O
the	O
thymus	O
and	O
may	O
play	O
a	O
role	O
for	O
the	O
development	O
of	O
the	O
immune	O
system	O
.	O

Moreover	O
,	O
its	O
overactivation	O
by	O
chemicals	O
such	O
as	O
dioxins	O
leads	O
to	O
immunosuppression	O
and	O
thymic	O
involution	O
.	O

Binding	O
motifs	O
for	O
the	O
liganded	B-protein
AHR	I-protein
can	O
be	O
identified	O
in	O
the	O
distal	B-DNA
region	I-DNA
-1300	I-DNA
to	I-DNA
-800	I-DNA
of	O
the	O
mouse	B-DNA
IL-2	I-DNA
promoter	I-DNA
.	O

We	O
show	O
here	O
that	O
these	O
DNA	B-DNA
motifs	I-DNA
,	O
the	O
so-called	O
dioxin	B-DNA
response	I-DNA
elements	I-DNA
,	O
after	O
binding	O
to	O
the	O
liganded	B-protein
AHR	I-protein
are	O
sufficient	O
to	O
transactivate	O
luciferase	O
expression	O
in	O
a	O
reporter	O
gene	O
system	O
.	O

The	O
IL-2	B-DNA
gene	I-DNA
can	O
be	O
induced	O
by	O
the	O
AHR	B-protein
also	O
in	O
thymocytes	B-cell_type
in	O
vivo	O
after	O
injection	O
of	O
2	O
,	O
3	O
,	O
7	O
,	O
8-tetrachlorodibenzo-p-dioxin	O
,	O
a	O
potent	O
ligand	O
of	O
the	O
AHR	B-protein
.	O

The	O
AHR	B-protein
mediates	O
the	O
IL-2	O
induction	O
as	O
shown	O
with	O
AHR	B-protein
-deficient	O
mice	O
.	O

However	O
,	O
in	O
spleen	B-cell_type
cells	I-cell_type
in	O
vitro	O
costimulation	O
via	O
the	O
TCR	B-protein
is	O
necessary	O
for	O
optimal	O
IL-2	B-DNA
gene	I-DNA
induction	O
.	O

Thus	O
,	O
the	O
IL-2	B-DNA
promoter	I-DNA
region	I-DNA
contains	O
novel	O
distal	B-DNA
regulatory	I-DNA
elements	I-DNA
that	O
can	O
be	O
addressed	O
by	O
the	O
AHR	B-protein
to	O
induce	O
IL-2	B-DNA
and	O
can	O
cooperate	O
with	O
the	O
proximal	B-DNA
promoter	I-DNA

3	NULL
<	NULL
.	NULL

a	NULL
el	NULL
(	NULL
ap	NULL
)	NULL
D	NULL
3	NULL
Reporter	NULL
Cell	NULL
Lines	NULL
a	NULL
a	NULL
g	NULL
The	NULL
film	NULL
”	NULL
)	NULL
!	NULL

keeps	NULL
growing	NULL
Learn	NULL
more	NULL
Ka	NULL
meJournal	NULL
o	NULL
The	NULL
Murine	NULL
ZL-2	NULL
Promoter	NULL
Contains	NULL
Distal	NULL
ﬁa	NULL
’	NULL
lmmunolo	NULL
gy	NULL
Regulatory	NULL
Elements	NULL
Responsive	NULL
to	NULL
the	NULL
Ah	NULL
Receptor	NULL
,	NULL
a	NULL
Member	NULL
of	NULL
the	NULL
Evolutionarily	NULL
Conserved	NULL
bHLH-PAS	NULL
Transcription	NULL
Factor	NULL
This	NULL
information	NULL
is	NULL
current	NULL
as	NULL
Family	NULL
of	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

Myung-Shin	NULL
Jeon	NULL
and	NULL
Charlotte	NULL
Esser	NULL
J	NULL
Immunol	NULL
2000	NULL
;	NULL
165:6975-6983	NULL
;	NULL
;	NULL
doi	NULL
:	NULL
10.4049/jimmunol.165.12.6975	NULL
http	NULL
:	NULL
//www	NULL
.jimmunol.org/content/165/12/6975	NULL
References	NULL
_	NULL
This	NULL
article	NULL
cites	NULL
49	NULL
articles	NULL
,	NULL
22	NULL
of	NULL
which	NULL
you	NULL
can	NULL
access	NULL
for	NULL
free	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www	NULL
.jimmunol.org/content/165/12/6975.full	NULL
#	NULL
ref-list-	NULL
1	NULL
Why	NULL
The	NULL
JT	NULL
?	NULL

Submit	NULL
online	NULL
.	NULL

«	NULL
Rapid	NULL
Reviews	NULL
!	NULL

30	NULL
days*	NULL
from	NULL
submission	NULL
to	NULL
initial	NULL
decision	NULL
*	NULL
No	NULL
Triage	NULL
!	NULL

Every	NULL
submission	NULL
reviewed	NULL
by	NULL
practicing	NULL
scientists	NULL
*	NULL
Fast	NULL
Publication	NULL
!	NULL

4	NULL
weeks	NULL
from	NULL
acceptance	NULL
to	NULL
publication	NULL
*average	NULL
Subscription	NULL
_-	NULL
Information	NULL
about	NULL
subscribing	NULL
to	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
is	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//jimmunol.org/subscription	NULL
Permissions	NULL
_	NULL
Submit	NULL
copyright	NULL
permission	NULL
requests	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.aai.org/About/Publications/Jl/copyright.html	NULL
Email	NULL
Alerts	NULL
_	NULL
Receive	NULL
free	NULL
email-alerts	NULL
when	NULL
new	NULL
articles	NULL
cite	NULL
this	NULL
article	NULL
.	NULL

Sign	NULL
up	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//jimmunol.org/alerts	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
is	NULL
published	NULL
twice	NULL
each	NULL
month	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
,	NULL
Inc.	NULL
,	NULL
1451	NULL
Rockville	NULL
Pike	NULL
,	NULL
Suite	NULL
650	NULL
,	NULL
Rockville	NULL
,	NULL
MD	NULL
20852	NULL
Copyright	NULL
©	NULL
2000	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
All	NULL
rights	NULL
reserved	NULL
.	NULL

Print	NULL
ISSN	NULL
:	NULL
0022-1767	NULL
Online	NULL
ISSN	NULL
:	NULL
1550-6606	NULL
.	NULL

6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
The	NULL
Murine	NULL
IL-2	NULL
Promoter	NULL
Contains	NULL
Distal	NULL
Regulatory	NULL
Elements	NULL
Responsive	NULL
to	NULL
the	NULL
Ah	NULL
Receptor	NULL
,	NULL
a	NULL
Member	NULL
of	NULL
the	NULL
Evolutionarily	NULL
Conserved	NULL
bHLH-PAS	NULL
Transcription	NULL
Factor	NULL
Family	NULL
'	NULL
Myung-Shin	NULL
Jeon	NULL
and	NULL
Charlotte	NULL
Esser	NULL
Signaling	NULL
through	NULL
the	NULL
TCR	NULL
and	NULL
costimulatory	NULL
signals	NULL
primarily	NULL
control	NULL
transcription	NULL
of	NULL
the	NULL
ZL-2	NULL
gene	NULL
in	NULL
naive	NULL
T	NULL
cells	NULL
.	NULL

The	NULL
minimal	NULL
promoter	NULL
necessary	NULL
for	NULL
this	NULL
expression	NULL
lies	NULL
proximal	NULL
,	NULL
between	NULL
-300	NULL
and	NULL
the	NULL
transcription	NULL
start	NULL
site	NULL
.	NULL

We	NULL
had	NULL
previously	NULL
shown	NULL
that	NULL
activation	NULL
of	NULL
the	NULL
arylhydrocarbon	NULL
receptor	NULL
(	NULL
AHR	NULL
)	NULL
,	NULL
a	NULL
member	NULL
of	NULL
the	NULL
bHLH-PAS	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
,	NULL
leads	NULL
to	NULL
increased	NULL
mRNA	NULL
expression	NULL
of	NULL
IL-2	NULL
in	NULL
murine	NULL
fetal	NULL
thymocytes	NULL
.	NULL

The	NULL
AHR	NULL
is	NULL
abundant	NULL
in	NULL
the	NULL
thymus	NULL
and	NULL
may	NULL
play	NULL
a	NULL
role	NULL
for	NULL
the	NULL
development	NULL
of	NULL
the	NULL
immune	NULL
system	NULL
.	NULL

Moreover	NULL
,	NULL
its	NULL
overactivation	NULL
by	NULL
chemicals	NULL
such	NULL
as	NULL
dioxins	NULL
leads	NULL
to	NULL
immunosuppression	NULL
and	NULL
thymic	NULL
involution	NULL
.	NULL

Binding	NULL
motifs	NULL
for	NULL
the	NULL
liganded	NULL
AHR	NULL
can	NULL
be	NULL
identified	NULL
in	NULL
the	NULL
distal	NULL
region	NULL
-1300	NULL
to	NULL
-800	NULL
of	NULL
the	NULL
mouse	NULL
IL-2	NULL
promoter	NULL
.	NULL

We	NULL
show	NULL
here	NULL
that	NULL
these	NULL
DNA	NULL
motifs	NULL
,	NULL
the	NULL
so-called	NULL
dioxin	NULL
response	NULL
elements	NULL
,	NULL
after	NULL
binding	NULL
to	NULL
the	NULL
liganded	NULL
AHR	NULL
are	NULL
sufficient	NULL
to	NULL
transactivate	NULL
luciferase	NULL
expression	NULL
in	NULL
a	NULL
reporter	NULL
gene	NULL
system	NULL
.	NULL

The	NULL
IL-2	NULL
gene	NULL
can	NULL
be	NULL
induced	NULL
by	NULL
the	NULL
AHR	NULL
also	NULL
in	NULL
thymocytes	NULL
in	NULL
vivo	NULL
after	NULL
injection	NULL
of	NULL
2,3,7,8-tetrachlorodibenzo-p-dioxin	NULL
,	NULL
a	NULL
potent	NULL
ligand	NULL
of	NULL
the	NULL
AHR	NULL
.	NULL

The	NULL
AHR	NULL
mediates	NULL
the	NULL
IL-2	NULL
induction	NULL
as	NULL
shown	NULL
with	NULL
AHR-deficient	NULL
mice	NULL
.	NULL

However	NULL
,	NULL
in	NULL
spleen	NULL
cells	NULL
in	NULL
vitro	NULL
costimulation	NULL
via	NULL
the	NULL
TCR	NULL
is	NULL
necessary	NULL
for	NULL
optimal	NULL
IL-2	NULL
gene	NULL
induction	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
IL-2	NULL
promoter	NULL
region	NULL
contains	NULL
novel	NULL
distal	NULL
regulatory	NULL
elements	NULL
that	NULL
can	NULL
be	NULL
addressed	NULL
by	NULL
the	NULL
AHR	NULL
to	NULL
induce	NULL
IL-2	NULL
and	NULL
can	NULL
cooperate	NULL
with	NULL
the	NULL
proximal	NULL
promoter	NULL
in	NULL
this	NULL
.	NULL

The	NULL
Journal	NULL
of	NULL
Immunology	NULL
,	NULL
2000	NULL
,	NULL
165	NULL
:	NULL
6975-6983.	NULL
intrinsic	NULL
and	NULL
extrinsic	NULL
factors	NULL
,	NULL
i.e	NULL
.	NULL

,	NULL
it	NULL
is	NULL
tissue	NULL
restricted	NULL
and	NULL
responsive	NULL
to	NULL
stimulation	NULL
by	NULL
Ags	NULL
or	NULL
other	NULL
stimuli	NULL
.	NULL

Studies	NULL
investigating	NULL
the	NULL
IL-2	NULL
promoter	NULL
have	NULL
focussed	NULL
on	NULL
the	NULL
proximal	NULL
regulatory	NULL
elements	NULL
.	NULL

The	NULL
region	NULL
extending	NULL
to	NULL
-300	NULL
has	NULL
been	NULL
identified	NULL
as	NULL
a	NULL
minimal	NULL
promoter	NULL
sufficient	NULL
for	NULL
expression	NULL
of	NULL
IL-2	NULL
in	NULL
response	NULL
to	NULL
antigenic	NULL
stimulation	NULL
via	NULL
the	NULL
TCR	NULL
plus	NULL
costimulatory	NULL
signals	NULL
such	NULL
as	NULL
interaction	NULL
of	NULL
CD28	NULL
and	NULL
B7	NULL
(	NULL
1	NULL
)	NULL
.	NULL

The	NULL
more	NULL
distal	NULL
regions	NULL
have	NULL
received	NULL
less	NULL
attention	NULL
,	NULL
albeit	NULL
in	NULL
the	NULL
original	NULL
publication	NULL
of	NULL
the	NULL
region	NULL
extending	NULL
-2800	NULL
bp	NULL
upstream	NULL
of	NULL
the	NULL
transcription	NULL
site	NULL
,	NULL
several	NULL
distal	NULL
regulatory	NULL
stretches	NULL
had	NULL
been	NULL
described	NULL
(	NULL
Ref	NULL
.	NULL

2	NULL
;	NULL
see	NULL
also	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

The	NULL
arylhydrocarbon	NULL
receptor	NULL
(	NULL
AHR	NULL
)	NULL
is	NULL
a	NULL
ligand-activated	NULL
transcription	NULL
factor	NULL
of	NULL
the	NULL
basic-helix-loop-helix-PAS	NULL
family	NULL
(	NULL
3	NULL
,	NULL
4	NULL
)	NULL
.	NULL

These	NULL
evolutionarily	NULL
conserved	NULL
proteins	NULL
are	NULL
involved	NULL
in	NULL
organo-genesis	NULL
,	NULL
cell	NULL
rhythm	NULL
,	NULL
and	NULL
detoxification	NULL
(	NULL
5	NULL
)	NULL
.	NULL

Whereas	NULL
the	NULL
natural	NULL
ligand	NULL
of	NULL
the	NULL
AHR	NULL
is	NULL
not	NULL
known	NULL
,	NULL
polyhalogenated	NULL
and	NULL
polycyclic	NULL
hydro-	NULL
I	NULL
:	NULL
xpression	NULL
of	NULL
the	NULL
ZL-2	NULL
gene	NULL
in	NULL
T	NULL
cells	NULL
is	NULL
highly	NULL
regulated	NULL
by	NULL
Division	NULL
of	NULL
Immunology	NULL
,	NULL
Medical	NULL
Institute	NULL
of	NULL
Environmental	NULL
Hygiene	NULL
at	NULL
the	NULL
University	NULL
of	NULL
Diisseldorf	NULL
,	NULL
Diisseldorf	NULL
,	NULL
Germany	NULL
Received	NULL
for	NULL
publication	NULL
February	NULL
24	NULL
,	NULL
2000	NULL
.	NULL

Accepted	NULL
for	NULL
publication	NULL
September	NULL
11	NULL
,	NULL
2000	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
adverfisement	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

*	NULL
This	NULL
work	NULL
was	NULL
supported	NULL
through	NULL
Sonderforschungsbereich	NULL
503	NULL
,	NULL
project	NULL
C5	NULL
,	NULL
by	NULL
the	NULL
Deutsche	NULL
Forschungsgemeinschaft	NULL
.	NULL

?	NULL

Address	NULL
correspondence	NULL
and	NULL
reprint	NULL
requests	NULL
to	NULL
Dr.	NULL
Charlotte	NULL
Esser	NULL
,	NULL
Division	NULL
of	NULL
Immunology	NULL
,	NULL
Medical	NULL
Institute	NULL
of	NULL
Environmental	NULL
Hygiene	NULL
,	NULL
Auf	NULL
m	NULL
Hennekamp	NULL
50	NULL
,	NULL
40225	NULL
Duesseldorf	NULL
,	NULL
Germany	NULL
.	NULL

3	NULL
Abbreviations	NULL
used	NULL
in	NULL
this	NULL
paper	NULL
:	NULL
AHR	NULL
,	NULL
arylhydrocarbon	NULL
receptor	NULL
;	NULL
ARNT	NULL
,	NULL
AHR	NULL
nuclear	NULL
translocator	NULL
;	NULL
DRE	NULL
,	NULL
dioxin	NULL
response	NULL
element	NULL
;	NULL
FTOC	NULL
,	NULL
fetal	NULL
thymus	NULL
organ	NULL
cul-ture	NULL
;	NULL
TCDD	NULL
,	NULL
2,3,7,8-tetrachlorodibenzo-p-dioxin	NULL
;	NULL
MMTV	NULL
,	NULL
mouse	NULL
mammary	NULL
tumor	NULL
virus	NULL
;	NULL
HPRT	NULL
,	NULL
hypoxanthine	NULL
phosphoribosyltransferase	NULL
;	NULL
ET	NULL
,	NULL
mouse	NULL
thymic	NULL
epithelial	NULL
cells	NULL
.	NULL

Copyright	NULL
©	NULL
2000	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
carbons	NULL
such	NULL
as	NULL
2,3,7,8-tetrachlorodibenzo-p-dioxin	NULL
(	NULL
TCDD	NULL
)	NULL
and	NULL
related	NULL
compounds	NULL
can	NULL
bind	NULL
and	NULL
activate	NULL
the	NULL
AHR	NULL
,	NULL
which	NULL
then	NULL
mediates	NULL
a	NULL
variety	NULL
of	NULL
toxic	NULL
responses	NULL
.	NULL

Depending	NULL
on	NULL
the	NULL
dose	NULL
of	NULL
the	NULL
activating	NULL
ligand	NULL
,	NULL
these	NULL
responses	NULL
can	NULL
vary	NULL
from	NULL
inmnmunosuppression	NULL
,	NULL
thymic	NULL
involution	NULL
,	NULL
endocrine	NULL
disruption	NULL
,	NULL
and	NULL
tumor	NULL
promotion	NULL
,	NULL
to	NULL
interference	NULL
with	NULL
fatty	NULL
acid	NULL
metabolism	NULL
and	NULL
cell	NULL
differentiation	NULL
(	NULL
6-9	NULL
)	NULL
.	NULL

Although	NULL
the	NULL
exact	NULL
mechanisms	NULL
of	NULL
the	NULL
various	NULL
toxic	NULL
responses	NULL
are	NULL
not	NULL
known	NULL
,	NULL
aberrant	NULL
induction	NULL
of	NULL
genes	NULL
has	NULL
been	NULL
assumed	NULL
to	NULL
be	NULL
a	NULL
major	NULL
factor	NULL
in	NULL
toxicity	NULL
.	NULL

Upon	NULL
ligand	NULL
binding	NULL
,	NULL
the	NULL
AHR	NULL
releases	NULL
its	NULL
chaperoning	NULL
heat	NULL
shock	NULL
protein	NULL
90	NULL
,	NULL
translocates	NULL
into	NULL
the	NULL
nucleus	NULL
,	NULL
and	NULL
dimerizes	NULL
with	NULL
AHR	NULL
nuclear	NULL
translocator	NULL
(	NULL
ARNT	NULL
)	NULL
(	NULL
10	NULL
)	NULL
.	NULL

The	NULL
heterodimeric	NULL
AHR-ARNT	NULL
complex	NULL
binds	NULL
to	NULL
a	NULL
short	NULL
DNA	NULL
motif	NULL
termed	NULL
DRE	NULL
(	NULL
dioxin	NULL
response	NULL
element	NULL
,	NULL
also	NULL
known	NULL
as	NULL
AHRE	NULL
or	NULL
XRE	NULL
)	NULL
and	NULL
alters	NULL
the	NULL
transcription	NULL
of	NULL
genes	NULL
controlled	NULL
by	NULL
DREs	NULL
.	NULL

Potential	NULL
DREs	NULL
are	NULL
found	NULL
in	NULL
many	NULL
genes	NULL
(	NULL
11	NULL
)	NULL
,	NULL
and	NULL
functional	NULL
studies	NULL
on	NULL
cytochrome	NULL
P-4501A1	NULL
have	NULL
been	NULL
pivotal	NULL
in	NULL
understanding	NULL
the	NULL
action	NULL
of	NULL
dioxins	NULL
in	NULL
gene	NULL
induction	NULL
(	NULL
12-14	NULL
)	NULL
.	NULL

It	NULL
is	NULL
conceivable	NULL
that	NULL
cytokines	NULL
are	NULL
important	NULL
in	NULL
mediating	NULL
the	NULL
biological	NULL
outcome	NULL
of	NULL
AHR	NULL
overactivation	NULL
in	NULL
the	NULL
immune	NULL
system	NULL
,	NULL
in	NULL
particular	NULL
the	NULL
immunosuppressive	NULL
effects	NULL
and	NULL
effects	NULL
on	NULL
thymus	NULL
development	NULL
.	NULL

Expression	NULL
of	NULL
several	NULL
cytokine	NULL
mRNAs	NULL
was	NULL
shown	NULL
to	NULL
be	NULL
inducible	NULL
by	NULL
TCDD	NULL
(	NULL
15	NULL
,	NULL
16	NULL
)	NULL
.	NULL

IL-2	NULL
,	NULL
which	NULL
is	NULL
comparatively	NULL
strongly	NULL
inducible	NULL
,	NULL
is	NULL
produced	NULL
by	NULL
T	NULL
cells	NULL
and	NULL
has	NULL
central	NULL
functions	NULL
for	NULL
growth	NULL
and	NULL
differentiation	NULL
of	NULL
T	NULL
cells	NULL
,	NULL
B	NULL
cells	NULL
,	NULL
NK	NULL
cells	NULL
,	NULL
and	NULL
macrophages	NULL
(	NULL
17	NULL
)	NULL
.	NULL

IL-2	NULL
is	NULL
mandatory	NULL
for	NULL
the	NULL
homeostasis	NULL
of	NULL
T	NULL
cells	NULL
(	NULL
18	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
direct	NULL
transcriptional	NULL
control	NULL
of	NULL
a	NULL
gene	NULL
of	NULL
the	NULL
immune	NULL
system	NULL
by	NULL
the	NULL
AHR	NULL
has	NULL
not	NULL
been	NULL
shown	NULL
until	NULL
now	NULL
.	NULL

Here	NULL
,	NULL
we	NULL
demonstrate	NULL
that	NULL
the	NULL
TCDD-activated	NULL
AHR	NULL
can	NULL
directly	NULL
bind	NULL
to	NULL
and	NULL
transduce	NULL
the	NULL
distal	NULL
region	NULL
of	NULL
the	NULL
IL-2	NULL
promoter	NULL
,	NULL
revealing	NULL
its	NULL
previously	NULL
unknown	NULL
enhancing	NULL
function	NULL
.	NULL

Depending	NULL
on	NULL
the	NULL
T	NULL
cell	NULL
maturation	NULL
stage	NULL
and	NULL
,	NULL
in	NULL
some	NULL
circumstances	NULL
,	NULL
costimulation	NULL
,	NULL
IL-2	NULL
will	NULL
be	NULL
expressed	NULL
upon	NULL
ligand	NULL
activation	NULL
of	NULL
the	NULL
AHR	NULL
in	NULL
thymus	NULL
and	NULL
spleen	NULL
cells	NULL
.	NULL

0022-1767/00/	NULL
$	NULL
02.00	NULL
6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
6976	NULL
IL-2	NULL
DISTAL	NULL
PROMOTER	NULL
ELEMENTS	NULL
REGULATED	NULL
BY	NULL
AH	NULL
RECEPTOR	NULL
Materials	NULL
and	NULL
Methods	NULL
In	NULL
vivo	NULL
treatment	NULL
of	NULL
mice	NULL
Female	NULL
C57BL/6	NULL
mice	NULL
(	NULL
Zentralinstitut	NULL
fiir	NULL
Versuchstierkunde	NULL
,	NULL
Hannover	NULL
,	NULL
Germany	NULL
)	NULL
and	NULL
AHR	NULL
homozygous	NULL
and	NULL
heterozygous	NULL
offspring	NULL
of	NULL
female	NULL
B6,1294kR	NULL
``	NULL
*	NULL
``	NULL
``	NULL
(	NULL
AhR	NULL
'~	NULL
)	NULL
and	NULL
male	NULL
C57BLGARR	NULL
'	NULL
``	NULL
**	NULL
``	NULL
``	NULL
(	NULL
AkR	NULL
'*	NULL
)	NULL
mice	NULL
(	NULL
The	NULL
Jackson	NULL
Laboratory	NULL
,	NULL
Bar	NULL
Harbor	NULL
,	NULL
ME	NULL
)	NULL
bred	NULL
in	NULL
our	NULL
animal	NULL
facility	NULL
were	NULL
used	NULL
.	NULL

All	NULL
animals	NULL
were	NULL
kept	NULL
under	NULL
specific	NULL
pathogen-free	NULL
conditions	NULL
.	NULL

For	NULL
in	NULL
vivo	NULL
exposure	NULL
,	NULL
TCDD	NULL
(	NULL
purity	NULL
>	NULL
99	NULL
%	NULL
;	NULL
Oekometric	NULL
GmbH	NULL
,	NULL
Bayreuth	NULL
,	NULL
Germany	NULL
)	NULL
was	NULL
dissolved	NULL
in	NULL
DMSO	NULL
and	NULL
diluted	NULL
in	NULL
sterile	NULL
corn	NULL
oil	NULL
to	NULL
5	NULL
ug/ml	NULL
.	NULL

Mice	NULL
were	NULL
injected	NULL
i.p	NULL
.	NULL

with	NULL
a	NULL
single	NULL
dose	NULL
of	NULL
50	NULL
ug	NULL
TCDD/kg	NULL
body	NULL
weight	NULL
.	NULL

Control	NULL
mice	NULL
received	NULL
DMSO/corn	NULL
oil	NULL
.	NULL

At	NULL
posttreatment	NULL
days	NULL
3	NULL
,	NULL
6	NULL
,	NULL
and	NULL
8	NULL
,	NULL
mice	NULL
were	NULL
killed	NULL
by	NULL
asphyxiation	NULL
,	NULL
and	NULL
RNA	NULL
was	NULL
extracted	NULL
from	NULL
thymi	NULL
and	NULL
spleens	NULL
with	NULL
TRIzol	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
instructions	NULL
(	NULL
Life	NULL
Technologies	NULL
,	NULL
Gaithersburg	NULL
,	NULL
MD	NULL
)	NULL
.	NULL

RNA	NULL
was	NULL
reverse	NULL
transcribed	NULL
by	NULL
standard	NULL
procedures	NULL
.	NULL

Before	NULL
RNA	NULL
extraction	NULL
,	NULL
erythrocytes	NULL
were	NULL
depleted	NULL
from	NULL
spleen	NULL
cells	NULL
by	NULL
hypotonic	NULL
lysis	NULL
.	NULL

Primary	NULL
cell	NULL
cultures	NULL
RPMI	NULL
1640	NULL
supplemented	NULL
with	NULL
5	NULL
%	NULL
FCS	NULL
,	NULL
5	NULL
X	NULL
10~*	NULL
M	NULL
2-ME	NULL
,	NULL
100	NULL
U/ml	NULL
penicillin	NULL
,	NULL
and	NULL
0.1	NULL
mg/ml	NULL
streptomycin	NULL
was	NULL
used	NULL
as	NULL
medium	NULL
throughout	NULL
.	NULL

TCDD	NULL
was	NULL
diluted	NULL
in	NULL
1,4-dioxane	NULL
(	NULL
Merck	NULL
,	NULL
Darmstadt	NULL
,	NULL
Germany	NULL
)	NULL
and	NULL
added	NULL
to	NULL
the	NULL
medium	NULL
at	NULL
a	NULL
final	NULL
concentration	NULL
of	NULL
10	NULL
nM	NULL
in	NULL
0.1	NULL
%	NULL
solvent	NULL
.	NULL

Anti-CD3e	NULL
was	NULL
coated	NULL
onto	NULL
six-well	NULL
plates	NULL
,	NULL
and	NULL
10-13	NULL
X	NULL
10°	NULL
thymocytes	NULL
or	NULL
5-7	NULL
X	NULL
10°	NULL
spleen	NULL
cells	NULL
from	NULL
adult	NULL
animals	NULL
were	NULL
added	NULL
in	NULL
2	NULL
ml	NULL
medium	NULL
with	NULL
10	NULL
nM	NULL
TCDD	NULL
or	NULL
solvent	NULL
alone	NULL
.	NULL

After	NULL
4	NULL
h	NULL
,	NULL
RNA	NULL
was	NULL
isolated	NULL
for	NULL
RT-PCR	NULL
.	NULL

In	NULL
other	NULL
experiments	NULL
,	NULL
supernatants	NULL
were	NULL
taken	NULL
after	NULL
the	NULL
indicated	NULL
incubation	NULL
times	NULL
with	NULL
anti-CD3e	NULL
,	NULL
and	NULL
IL-2	NULL
content	NULL
was	NULL
measured	NULL
by	NULL
ELISA	NULL
(	NULL
Mouse	NULL
ELISA	NULL
kit	NULL
;	NULL
Endogen	NULL
,	NULL
Woburn	NULL
,	NULL
MA	NULL
)	NULL
.	NULL

Alternatively	NULL
,	NULL
fetal	NULL
thymus	NULL
lobes	NULL
from	NULL
mice	NULL
at	NULL
gestation	NULL
day	NULL
15	NULL
were	NULL
excised	NULL
,	NULL
freed	NULL
of	NULL
adhering	NULL
tissue	NULL
,	NULL
and	NULL
cultivated	NULL
on	NULL
nitrocellulose	NULL
filters	NULL
set	NULL
in	NULL
a	NULL
well	NULL
with	NULL
300	NULL
pl	NULL
medium	NULL
plus	NULL
or	NULL
minus	NULL
10	NULL
nM	NULL
TCDD	NULL
as	NULL
described	NULL
before	NULL
(	NULL
19-21	NULL
)	NULL
.	NULL

Control	NULL
lobes	NULL
were	NULL
cultivated	NULL
in	NULL
medium	NULL
plus	NULL
0.1	NULL
%	NULL
solvent	NULL
alone	NULL
.	NULL

At	NULL
4	NULL
or	NULL
5	NULL
days	NULL
of	NULL
culture	NULL
,	NULL
single-cell	NULL
suspensions	NULL
were	NULL
prepared	NULL
,	NULL
and	NULL
RNA	NULL
was	NULL
extracted	NULL
and	NULL
reverse	NULL
transcribed	NULL
.	NULL

For	NULL
analysis	NULL
of	NULL
thymocyte	NULL
subpopulations	NULL
,	NULL
CD4~CD8~	NULL
,	NULL
CD4*CD8*	NULL
,	NULL
CD4~CD8*	NULL
,	NULL
and	NULL
CD4*CD8~	NULL
thymocytes	NULL
were	NULL
sorted	NULL
on	NULL
a	NULL
FACS440	NULL
cell	NULL
sorter	NULL
(	NULL
Becton	NULL
Dickinson	NULL
,	NULL
Mountain	NULL
View	NULL
,	NULL
CA	NULL
)	NULL
after	NULL
staining	NULL
with	NULL
anti-CD4	NULL
and	NULL
anti-CD8	NULL
Abs	NULL
(	NULL
PharMingen	NULL
,	NULL
Hamburg	NULL
,	NULL
Germany	NULL
)	NULL
.	NULL

RT-PCR	NULL
assays	NULL
Semiquantitative	NULL
RT-PCR	NULL
assays	NULL
were	NULL
performed	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
15	NULL
)	NULL
.	NULL

Total	NULL
RNA	NULL
(	NULL
1	NULL
ug	NULL
)	NULL
was	NULL
used	NULL
for	NULL
cDNA	NULL
synthesis	NULL
with	NULL
mouse	NULL
mammary	NULL
tumor	NULL
virus	NULL
(	NULL
MMTV	NULL
)	NULL
reverse	NULL
transcriptase	NULL
.	NULL

[	NULL
a-*~P	NULL
]	NULL
-labeled	NULL
CTP	NULL
was	NULL
added	NULL
during	NULL
RT-PCR	NULL
.	NULL

HPRT	NULL
(	NULL
hypoxanthine	NULL
phosphoribosyltransferase	NULL
;	NULL
Ref	NULL
.	NULL

22	NULL
)	NULL
,	NULL
a	NULL
housekeeping	NULL
gene	NULL
,	NULL
was	NULL
amplified	NULL
together	NULL
with	NULL
the	NULL
cDNA	NULL
of	NULL
IL-2	NULL
in	NULL
the	NULL
same	NULL
reaction	NULL
tube	NULL
.	NULL

To	NULL
analyze	NULL
the	NULL
amplification	NULL
of	NULL
both	NULL
cDNAs	NULL
in	NULL
the	NULL
linear	NULL
range	NULL
,	NULL
the	NULL
``	NULL
primer-dropping	NULL
``	NULL
method	NULL
(	NULL
23	NULL
)	NULL
was	NULL
used	NULL
to	NULL
calibrate	NULL
for	NULL
the	NULL
different	NULL
expression	NULL
levels	NULL
of	NULL
HPRT	NULL
vs	NULL
IL-2	NULL
cDNAs	NULL
.	NULL

Briefly	NULL
,	NULL
the	NULL
cDNA	NULL
for	NULL
the	NULL
IL-2	NULL
test	NULL
were	NULL
first	NULL
amplified	NULL
for	NULL
several	NULL
cycles	NULL
(	NULL
depend-ing	NULL
on	NULL
their	NULL
previously	NULL
established	NULL
abundance	NULL
)	NULL
,	NULL
and	NULL
then	NULL
HPRT	NULL
primers	NULL
were	NULL
dropped	NULL
into	NULL
the	NULL
reaction	NULL
tubes	NULL
followed	NULL
by	NULL
an	NULL
additional	NULL
25	NULL
cycles	NULL
.	NULL

PCR	NULL
products	NULL
were	NULL
separated	NULL
on	NULL
10	NULL
%	NULL
polyacrylamide	NULL
gels	NULL
.	NULL

Gels	NULL
were	NULL
dried	NULL
and	NULL
visualized	NULL
by	NULL
autoradiography	NULL
.	NULL

The	NULL
primer	NULL
sequences	NULL
,	NULL
the	NULL
annealing	NULL
temperature	NULL
,	NULL
and	NULL
cycles	NULL
for	NULL
RT-PCR	NULL
are	NULL
shown	NULL
in	NULL
Table	NULL
I	NULL
.	NULL

The	NULL
autoradiographs	NULL
were	NULL
analyzed	NULL
with	NULL
an	NULL
OmniMedia	NULL
scanner	NULL
and	NULL
the	NULL
whole-band	NULL
analysis	NULL
program	NULL
(	NULL
Bio	NULL
Image	NULL
system	NULL
;	NULL
Millipore	NULL
,	NULL
Bedford	NULL
,	NULL
MA	NULL
)	NULL
.	NULL

Quantifi-cation	NULL
was	NULL
performed	NULL
on	NULL
autoradiographs	NULL
in	NULL
the	NULL
linear	NULL
range	NULL
of	NULL
radioactivity	NULL
to	NULL
photosensitivity	NULL
.	NULL

PCR	NULL
experiments	NULL
for	NULL
each	NULL
gene	NULL
expression	NULL
were	NULL
performed	NULL
at	NULL
least	NULL
two	NULL
times	NULL
with	NULL
similar	NULL
results	NULL
;	NULL
for	NULL
data	NULL
presentation	NULL
,	NULL
one	NULL
representative	NULL
experiment	NULL
is	NULL
shown	NULL
.	NULL

EMSA	NULL
Complementary	NULL
single-stranded	NULL
oligonucleotides	NULL
were	NULL
synthesized	NULL
,	NULL
annealed	NULL
,	NULL
and	NULL
end-labeled	NULL
with	NULL
[	NULL
y-	NULL
``	NULL
``	NULL
P	NULL
]	NULL
ATP	NULL
.	NULL

Sequences	NULL
of	NULL
oligonucleotides	NULL
are	NULL
shown	NULL
in	NULL
Table	NULL
II	NULL
.	NULL

Nuclear	NULL
and	NULL
cytoplasmic	NULL
proteins	NULL
from	NULL
an	NULL
ARR	NULL
``	NULL
mouse	NULL
thymic	NULL
epithelial	NULL
cell	NULL
line	NULL
,	NULL
ET	NULL
(	NULL
a	NULL
gift	NULL
from	NULL
Ronald	NULL
Palacios	NULL
,	NULL
Basel	NULL
Institute	NULL
of	NULL
Immunology	NULL
,	NULL
Basel	NULL
,	NULL
Switzerland	NULL
;	NULL
Ref	NULL
.	NULL

24	NULL
)	NULL
,	NULL
were	NULL
prepared	NULL
(	NULL
25	NULL
)	NULL
and	NULL
EMSA	NULL
were	NULL
essentially	NULL
performed	NULL
as	NULL
described	NULL
(	NULL
26	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
15	NULL
ug	NULL
of	NULL
nuclear	NULL
proteins	NULL
were	NULL
incubated	NULL
with	NULL
30,000	NULL
cpm	NULL
end-labeled	NULL
double-stranded	NULL
oligonucleotides	NULL
for	NULL
20	NULL
min	NULL
in	NULL
a	NULL
final	NULL
volume	NULL
of	NULL
15	NULL
pl	NULL
.	NULL

Binding	NULL
reactions	NULL
were	NULL
conducted	NULL
in	NULL
25	NULL
mM	NULL
HEPES	NULL
,	NULL
pH	NULL
7.5	NULL
;	NULL
1	NULL
mM	NULL
EDTA	NULL
;	NULL
0.7	NULL
mM	NULL
DTT	NULL
;	NULL
0.5	NULL
mM	NULL
PMSF	NULL
;	NULL
10	NULL
%	NULL
glycerol	NULL
;	NULL
and	NULL
156	NULL
mM	NULL
KCI	NULL
.	NULL

Samples	NULL
were	NULL
preincubated	NULL
for	NULL
10	NULL
min	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
1	NULL
ug	NULL
poly	NULL
d	NULL
(	NULL
LC	NULL
)	NULL
d	NULL
(	NULL
I	NULL
:	NULL
C	NULL
)	NULL
and	NULL
0.5	NULL
g	NULL
salmon	NULL
sperm	NULL
DNA	NULL
.	NULL

A	NULL
200-fold	NULL
excess	NULL
of	NULL
unlabeled	NULL
oligonucleotides	NULL
was	NULL
used	NULL
in	NULL
specific	NULL
and	NULL
nonspecific	NULL
competition	NULL
experiments	NULL
.	NULL

AHR-DRE	NULL
complexes	NULL
were	NULL
separated	NULL
on	NULL
4	NULL
%	NULL
(	NULL
w/v	NULL
)	NULL
polyacrylamide	NULL
gels	NULL
in	NULL
TGE	NULL
buffer	NULL
(	NULL
50	NULL
mM	NULL
Tris	NULL
,	NULL
380	NULL
mM	NULL
glycin	NULL
,	NULL
2	NULL
mM	NULL
EDTA	NULL
,	NULL
pH	NULL
8.5	NULL
)	NULL
.	NULL

Gels	NULL
were	NULL
transferred	NULL
to	NULL
Whatman	NULL
3	NULL
MM	NULL
paper	NULL
(	NULL
Bio-Rad	NULL
,	NULL
Munich	NULL
,	NULL
Germany	NULL
)	NULL
,	NULL
dried	NULL
,	NULL
and	NULL
auto-radiographed	NULL
.	NULL

For	NULL
supershift	NULL
analyses	NULL
,	NULL
the	NULL
nuclear	NULL
protein	NULL
extract	NULL
and	NULL
labeled	NULL
oligonucleotide	NULL
were	NULL
incubated	NULL
with	NULL
1	NULL
or	NULL
3	NULL
pl	NULL
of	NULL
anti-AHR	NULL
Ab	NULL
(	NULL
Di-anova	NULL
,	NULL
Hamburg	NULL
,	NULL
Germany	NULL
)	NULL
for	NULL
10	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
before	NULL
gel	NULL
electrophoresis	NULL
.	NULL

Plasmid	NULL
constructs	NULL
,	NULL
transfection	NULL
,	NULL
and	NULL
luciferase	NULL
assays	NULL
The	NULL
plasmid	NULL
constructs	NULL
used	NULL
in	NULL
this	NULL
study	NULL
were	NULL
as	NULL
follows	NULL
:	NULL
pGudLuc	NULL
1.0	NULL
,	NULL
a	NULL
reporter	NULL
plasmid	NULL
containing	NULL
the	NULL
firefly	NULL
luciferase	NULL
gene	NULL
under	NULL
the	NULL
control	NULL
of	NULL
the	NULL
MMTV	NULL
promoter	NULL
;	NULL
pGudLuc	NULL
1.1	NULL
,	NULL
produced	NULL
by	NULL
cloning	NULL
five	NULL
DREs	NULL
(	NULL
-1301	NULL
to	NULL
-819	NULL
)	NULL
isolated	NULL
from	NULL
the	NULL
CYPIAI	NULL
promoter	NULL
of	NULL
mouse	NULL
into	NULL
the	NULL
MMTV	NULL
promoter	NULL
of	NULL
pGudLuc	NULL
1.0	NULL
(	NULL
both	NULL
plasmids	NULL
were	NULL
gifts	NULL
from	NULL
Michael	NULL
Denison	NULL
,	NULL
University	NULL
of	NULL
California	NULL
at	NULL
Davis	NULL
;	NULL
Ref	NULL
.	NULL

29	NULL
)	NULL
and	NULL
used	NULL
as	NULL
positive	NULL
control	NULL
in	NULL
all	NULL
assays	NULL
;	NULL
pMMTV-IL-2-DRE	NULL
(	NULL
O.5	NULL
)	NULL
,	NULL
produced	NULL
by	NULL
cloning	NULL
the	NULL
Esp3	NULL
1-Sspl	NULL
fragment	NULL
spanning	NULL
-1296	NULL
to	NULL
-756	NULL
of	NULL
the	NULL
5	NULL
'	NULL
region	NULL
of	NULL
the	NULL
ZL-2	NULL
gene	NULL
and	NULL
containing	NULL
the	NULL
three	NULL
DREs	NULL
into	NULL
the	NULL
Bg/I	NULL
site	NULL
within	NULL
the	NULL
MMTV	NULL
promoter	NULL
of	NULL
the	NULL
pGudluec	NULL
1.0	NULL
vector	NULL
;	NULL
pDRE	NULL
(	NULL
O.5	NULL
)	NULL
MutI/III	NULL
and	NULL
pDRE	NULL
(	NULL
O.5	NULL
)	NULL
MutIII	NULL
,	NULL
in	NULL
these	NULL
plasmids	NULL
,	NULL
point	NULL
mutations	NULL
of	NULL
the	NULL
DREII/III	NULL
or	NULL
only	NULL
DREIII	NULL
had	NULL
been	NULL
introduced	NULL
into	NULL
the	NULL
core	NULL
recognition	NULL
sites	NULL
of	NULL
pMTV-IL-2-DRE	NULL
(	NULL
0.5	NULL
)	NULL
;	NULL
pDRE	NULL
I	NULL
,	NULL
pDRE	NULL
II	NULL
,	NULL
and	NULL
pDRE	NULL
III	NULL
,	NULL
complementary	NULL
single-stranded	NULL
oligonucleotides	NULL
(	NULL
50	NULL
bases	NULL
)	NULL
encoding	NULL
two	NULL
copies	NULL
of	NULL
each	NULL
DRE	NULL
of	NULL
IL-2	NULL
promoter	NULL
and	NULL
were	NULL
synthesized	NULL
,	NULL
annealed	NULL
,	NULL
and	NULL
cloned	NULL
into	NULL
the	NULL
Bg/lI	NULL
site	NULL
of	NULL
pGudluc	NULL
1.0	NULL
(	NULL
Table	NULL
III	NULL
)	NULL
.	NULL

The	NULL
DNA	NULL
sequences	NULL
of	NULL
the	NULL
oligonucleotides	NULL
are	NULL
shown	NULL
in	NULL
Table	NULL
III	NULL
(	NULL
the	NULL
core	NULL
recognition	NULL
sequence	NULL
for	NULL
the	NULL
DRE	NULL
motifs	NULL
is	NULL
in	NULL
bold	NULL
print	NULL
)	NULL
;	NULL
pSV-IL-2-DRE	NULL
(	NULL
O0.5	NULL
)	NULL
and	NULL
pTK-IL-2DRE	NULL
(	NULL
O.5	NULL
)	NULL
,	NULL
the	NULL
IL-2	NULL
fragment	NULL
-1296	NULL
to	NULL
-756	NULL
was	NULL
cloned	NULL
into	NULL
the	NULL
pGL3P	NULL
vector	NULL
in	NULL
front	NULL
of	NULL
the	NULL
SV40	NULL
promoter	NULL
or	NULL
TK	NULL
promoter	NULL
(	NULL
Promega	NULL
,	NULL
Madison	NULL
,	NULL
WI	NULL
)	NULL
,	NULL
respectively	NULL
.	NULL

pSV-IL-2-DRE	NULL
(	NULL
O.1	NULL
)	NULL
,	NULL
the	NULL
BstEII	NULL
to	NULL
Nsil	NULL
fragment	NULL
(	NULL
400	NULL
bp	NULL
)	NULL
between	NULL
DRE	NULL
I	NULL
and	NULL
DRE	NULL
II	NULL
of	NULL
the	NULL
IL-2	NULL
5	NULL
``	NULL
region	NULL
,	NULL
was	NULL
deleted	NULL
from	NULL
pSV-IL-2-DRE	NULL
(	NULL
O.5	NULL
)	NULL
.	NULL

All	NULL
plasmids	NULL
were	NULL
examined	NULL
by	NULL
sequencing	NULL
.	NULL

Expression	NULL
of	NULL
AHR	NULL
and	NULL
its	NULL
dimerization	NULL
partner	NULL
ARNT	NULL
,	NULL
both	NULL
necessary	NULL
for	NULL
TCDD-mediated	NULL
gene	NULL
transactivation	NULL
,	NULL
was	NULL
verified	NULL
by	NULL
RT-PCR	NULL
in	NULL
the	NULL
human	NULL
HepG2	NULL
hepatoma	NULL
cells	NULL
and	NULL
in	NULL
mouse	NULL
lines	NULL
Hepa	NULL
C1	NULL
,	NULL
Hepa	NULL
C12	NULL
,	NULL
and	NULL
Hepa	NULL
C4	NULL
(	NULL
gifts	NULL
from	NULL
Oliver	NULL
Hankinson	NULL
,	NULL
University	NULL
of	NULL
California	NULL
at	NULL
Los	NULL
Angeles	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
grown	NULL
in	NULL
culture	NULL
medium	NULL
with	NULL
10	NULL
%	NULL
FCS	NULL
.	NULL

Cells	NULL
(	NULL
5	NULL
%	NULL
10°	NULL
)	NULL
were	NULL
cultured	NULL
overnight	NULL
in	NULL
six-well	NULL
plates	NULL
.	NULL

Cells	NULL
were	NULL
washed	NULL
twice	NULL
with	NULL
PBS	NULL
and	NULL
transfected	NULL
with	NULL
2	NULL
pug	NULL
plasmid	NULL
DNA	NULL
(	NULL
pGudLuc	NULL
1.0	NULL
,	NULL
pMMTV-IL-2-DRE	NULL
(	NULL
O.5	NULL
)	NULL
,	NULL
the	NULL
point	NULL
mutation	NULL
derivatives	NULL
thereof	NULL
,	NULL
pDRE	NULL
I	NULL
,	NULL
pDRE	NULL
II	NULL
,	NULL
pDRE	NULL
III	NULL
,	NULL
pSV-IL-2-DRE	NULL
(	NULL
0.5	NULL
)	NULL
,	NULL
pSV-IL-2-DRE	NULL
(	NULL
0.1	NULL
)	NULL
,	NULL
or	NULL
pGudluc	NULL
1.1	NULL
)	NULL
.	NULL

Transfections	NULL
were	NULL
performed	NULL
with	NULL
8	NULL
ug	NULL
transfectam	NULL
(	NULL
Promega	NULL
)	NULL
in	NULL
1	NULL
ml	NULL
RPMI	NULL
1640	NULL
.	NULL

After	NULL
8	NULL
h	NULL
,	NULL
4	NULL
ml	NULL
complete	NULL
culture	NULL
medium	NULL
were	NULL
added	NULL
.	NULL

Cells	NULL
were	NULL
cultured	NULL
for	NULL
another	NULL
16	NULL
h	NULL
before	NULL
adding	NULL
10	NULL
nM	NULL
TCDD	NULL
or	NULL
solvent	NULL
alone	NULL
.	NULL

After	NULL
14-16	NULL
h	NULL
,	NULL
cells	NULL
were	NULL
lysed	NULL
,	NULL
and	NULL
luciferase	NULL
activity	NULL
was	NULL
measured	NULL
in	NULL
a	NULL
luminometer	NULL
(	NULL
LP96	NULL
P-Luminometer	NULL
;	NULL
Berthold	NULL
,	NULL
Nashua	NULL
,	NULL
NH	NULL
)	NULL
.	NULL

Results	NULL
were	NULL
normalized	NULL
to	NULL
the	NULL
amount	NULL
of	NULL
total	NULL
protein	NULL
in	NULL
the	NULL
cell	NULL
lysate	NULL
,	NULL
measured	NULL
by	NULL
the	NULL
Bradford	NULL
assay	NULL
(	NULL
Bio-Rad	NULL
)	NULL
.	NULL

Results	NULL
The	NULL
TCDD-activated	NULL
AHR	NULL
binds	NULL
to	NULL
the	NULL
DREs	NULL
in	NULL
the	NULL
IL-2	NULL
distal	NULL
promoter	NULL
region	NULL
In	NULL
previous	NULL
studies	NULL
we	NULL
had	NULL
shown	NULL
that	NULL
IL-2	NULL
,	NULL
TNF-a	NULL
,	NULL
and	NULL
IL-18	NULL
mRNA	NULL
are	NULL
inducible	NULL
in	NULL
a	NULL
dose-dependent	NULL
fashion	NULL
by	NULL
TCDD	NULL
in	NULL
Table	NULL
I	NULL
.	NULL

-	NULL
Oligonucleotide	NULL
primers	NULL
used	NULL
for	NULL
gene	NULL
expression	NULL
analysis	NULL
by	NULL
RT-PCR	NULL
Gene	NULL
Primer	NULL
Sequence	NULL
bp	NULL
T	NULL
(	NULL
°C	NULL
)	NULL
``	NULL
Cycle	NULL
Reference	NULL
IL-2	NULL
5'-ATGTACAGCATGCAGTCTGCATC-3	NULL
'	NULL
502	NULL
59	NULL
33-35	NULL
15	NULL
5'-GGCTTGTTGAGATGATGCTTTGACA-3	NULL
'	NULL
HPRT	NULL
5'-GCTGGTGAAAAGGACCTCT-3	NULL
'	NULL
249	NULL
59	NULL
25-22	NULL
22	NULL
5'-CACAGGACTAGAACACCTGC-3	NULL
'	NULL
``	NULL
Annealing	NULL
temperature	NULL
.	NULL

6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
Table	NULL
II	NULL
.	NULL

-	NULL
Oligonucleotides	NULL
used	NULL
in	NULL
bandshift	NULL
assays	NULL
``	NULL
6977	NULL
Gene	NULL
Sequence	NULL
Ref	NULL
.	NULL

IL-2	NULL
DRE	NULL
I	NULL
-1270	NULL
5'-TTCCTACTCCATCACGCAGCCAGTGT-3	NULL
'	NULL
11	NULL
-3'-ATGAGGTAGTGCGTCGGTCACACATGAT-5	NULL
'	NULL
-1241	NULL
IL-2	NULL
DRE	NULL
II	NULL
-860	NULL
5	NULL
``	NULL
-CACTCATATACACACGCACATAAACA-3	NULL
'	NULL
11	NULL
3'-GTATATGTIGTGCGTGTATTITIGTIACGA-5	NULL
'	NULL
-831	NULL
IL-2	NULL
DRE	NULL
II	NULL
-823	NULL
5'-ACATACATGTGCACGCACATGCACAT-3	NULL
'	NULL
11	NULL
3'-TGTACACGTGCGTGTACGTGTATGAG-5	NULL
'	NULL
-794	NULL
Human	NULL
CYP1A1	NULL
(	NULL
hDRE12	NULL
)	NULL
-998	NULL
5'-GATCTCCGGTCCTTCTCACGCAACGCCTGGec-3	NULL
'	NULL
27	NULL
3'-AGGCCAGGAAGAGTGCGTTGCGGACCCGCTAG-3	NULL
'	NULL
-973	NULL
NS-4	NULL
5'-ATGAATATGCAAATCAGGTG-3	NULL
'	NULL
28	NULL
3'-TACTTATACGTTTAGTCCAC-5	NULL
'	NULL
*	NULL
DRE	NULL
consensus	NULL
sequences	NULL
are	NULL
determined	NULL
as	NULL
5	NULL
``	NULL
-T	NULL
G/C	NULL
G/T	NULL
CACGC	NULL
N	NULL
C/A-3	NULL
'	NULL
.	NULL

Bold	NULL
letters	NULL
designated	NULL
the	NULL
actual	NULL
CACGC	NULL
AHR	NULL
contact	NULL
site	NULL
,	NULL
underlined	NULL
letters	NULL
deviate	NULL
from	NULL
the	NULL
consensus	NULL
sequence	NULL
(	NULL
14	NULL
)	NULL
.	NULL

For	NULL
mutation	NULL
experiments	NULL
,	NULL
the	NULL
last	NULL
C	NULL
in	NULL
CACGC	NULL
was	NULL
changed	NULL
to	NULL
a	NULL
T.	NULL
thymocytes	NULL
.	NULL

Except	NULL
TNF-a	NULL
,	NULL
these	NULL
cytokines	NULL
contain	NULL
consensus	NULL
sequence	NULL
of	NULL
DREs	NULL
in	NULL
the	NULL
published	NULL
upstream	NULL
region	NULL
of	NULL
their	NULL
respective	NULL
genes	NULL
(	NULL
11	NULL
)	NULL
.	NULL

The	NULL
IL-2	NULL
gene	NULL
has	NULL
three	NULL
potential	NULL
DRE	NULL
sites	NULL
at	NULL
-1261	NULL
,	NULL
-851	NULL
,	NULL
and	NULL
-815	NULL
bp	NULL
.	NULL

We	NULL
decided	NULL
to	NULL
test	NULL
the	NULL
three	NULL
DREs	NULL
of	NULL
the	NULL
IL-2	NULL
distal	NULL
promoter	NULL
region	NULL
for	NULL
direct	NULL
interaction	NULL
and	NULL
inducibility	NULL
by	NULL
the	NULL
liganded	NULL
AHR	NULL
.	NULL

Expression	NULL
of	NULL
AHR	NULL
and	NULL
its	NULL
dimerization	NULL
partner	NULL
ARNT	NULL
,	NULL
both	NULL
necessary	NULL
for	NULL
TCDD-mediated	NULL
gene	NULL
transactivation	NULL
,	NULL
was	NULL
verified	NULL
by	NULL
RT-PCR	NULL
in	NULL
the	NULL
ET	NULL
thymic	NULL
epithelial	NULL
cell	NULL
line	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Also	NULL
,	NULL
expression	NULL
of	NULL
CYPIAI	NULL
,	NULL
a	NULL
known	NULL
TCDD-responsive	NULL
gene	NULL
(	NULL
3	NULL
,	NULL
12	NULL
)	NULL
,	NULL
was	NULL
inducible	NULL
by	NULL
TCDD	NULL
in	NULL
this	NULL
cell	NULL
line	NULL
,	NULL
indicating	NULL
the	NULL
functionality	NULL
of	NULL
the	NULL
endogenous	NULL
AHR	NULL
and	NULL
ARNT	NULL
proteins	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Nuclear	NULL
extracts	NULL
of	NULL
ET	NULL
cells	NULL
,	NULL
containing	NULL
the	NULL
AHR/ARNT	NULL
complex	NULL
,	NULL
did	NULL
bind	NULL
to	NULL
labeled	NULL
IL-2-DRE-oligonucleotides	NULL
only	NULL
when	NULL
treated	NULL
with	NULL
TCDD	NULL
but	NULL
not	NULL
with	NULL
solvent	NULL
alone	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
)	NULL
.	NULL

No	NULL
specific	NULL
AHR	NULL
binding	NULL
was	NULL
observed	NULL
with	NULL
cytoplasmic	NULL
protein	NULL
,	NULL
indicating	NULL
that	NULL
TCDD-dependent	NULL
dimerization	NULL
of	NULL
AHR	NULL
and	NULL
ARNT	NULL
takes	NULL
place	NULL
in	NULL
the	NULL
nucleus	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

Specificity	NULL
of	NULL
binding	NULL
was	NULL
demonstrated	NULL
by	NULL
competition	NULL
experiments	NULL
using	NULL
unlabeled	NULL
ZL-2-DRE	NULL
oligonucleotides	NULL
or	NULL
the	NULL
DRE	NULL
of	NULL
CYPIA1	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
,	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
)	NULL
.	NULL

Binding	NULL
was	NULL
not	NULL
inhibited	NULL
with	NULL
oligo-DNA	NULL
of	NULL
an	NULL
unrelated	NULL
sequence	NULL
(	NULL
Fig	NULL
.	NULL

14	NULL
,	NULL
lane	NULL
5	NULL
)	NULL
.	NULL

Preincuba-tion	NULL
of	NULL
the	NULL
mixture	NULL
of	NULL
nuclear	NULL
extracts	NULL
and	NULL
DREs	NULL
with	NULL
anti-AHR	NULL
Abs	NULL
led	NULL
to	NULL
the	NULL
expected	NULL
supershift	NULL
of	NULL
the	NULL
complex	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
,	NULL
lanes	NULL
6	NULL
and	NULL
7	NULL
)	NULL
.	NULL

The	NULL
three	NULL
DREs	NULL
differed	NULL
in	NULL
their	NULL
binding	NULL
capacity	NULL
.	NULL

In	NULL
particular	NULL
,	NULL
the	NULL
binding	NULL
of	NULL
DRE	NULL
I	NULL
was	NULL
much	NULL
weaker	NULL
than	NULL
that	NULL
of	NULL
DRE	NULL
II	NULL
and	NULL
DRE	NULL
IIL	NULL
.	NULL

This	NULL
is	NULL
in	NULL
agreement	NULL
with	NULL
the	NULL
deviation	NULL
from	NULL
the	NULL
published	NULL
consensus	NULL
sequence	NULL
5'-T	NULL
G/C	NULL
G/T	NULL
CACGC	NULL
N	NULL
C/A-3	NULL
'	NULL
(	NULL
14	NULL
)	NULL
,	NULL
which	NULL
is	NULL
three	NULL
base	NULL
pair	NULL
for	NULL
DRE	NULL
I	NULL
,	NULL
but	NULL
only	NULL
two	NULL
for	NULL
DRE	NULL
II	NULL
and	NULL
DRE	NULL
III	NULL
(	NULL
see	NULL
Table	NULL
II	NULL
)	NULL
.	NULL

Still	NULL
,	NULL
the	NULL
core	NULL
sequence	NULL
,	NULL
to	NULL
which	NULL
the	NULL
AHR/ARNT/TCDD	NULL
complex	NULL
makes	NULL
physical	NULL
contact	NULL
(	NULL
14	NULL
,	NULL
28	NULL
)	NULL
,	NULL
is	NULL
unchanged	NULL
in	NULL
all	NULL
three	NULL
DREs	NULL
.	NULL

Note	NULL
that	NULL
DRE	NULL
I	NULL
binds	NULL
to	NULL
proteins	NULL
of	NULL
an	NULL
unknown	NULL
nature	NULL
,	NULL
albeit	NULL
this	NULL
complex	NULL
is	NULL
not	NULL
shifted	NULL
by	NULL
TCDD	NULL
treatment	NULL
.	NULL

The	NULL
IL-2	NULL
distal	NULL
region	NULL
contains	NULL
enhancer	NULL
elements	NULL
responsive	NULL
to	NULL
TCDD	NULL
To	NULL
test	NULL
whether	NULL
TCDD	NULL
leads	NULL
to	NULL
transactivation	NULL
of	NULL
the	NULL
AHR	NULL
on	NULL
the	NULL
IL-2-DREs	NULL
,	NULL
we	NULL
transiently	NULL
transfected	NULL
hepatoma	NULL
cells	NULL
with	NULL
pM-MTV-IL-2-DRE	NULL
,	NULL
a	NULL
reporter	NULL
plasmid	NULL
containing	NULL
luciferase	NULL
under	NULL
the	NULL
control	NULL
of	NULL
the	NULL
-1296	NULL
to	NULL
-756	NULL
region	NULL
of	NULL
the	NULL
5	NULL
'	NULL
IL-2	NULL
gene	NULL
.	NULL

We	NULL
then	NULL
measured	NULL
the	NULL
induction	NULL
of	NULL
luciferase	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

Hepatoma	NULL
cells	NULL
were	NULL
used	NULL
because	NULL
of	NULL
unresolvable	NULL
technical	NULL
difficulties	NULL
in	NULL
efficiently	NULL
transfecting	NULL
primary	NULL
T	NULL
cells	NULL
or	NULL
thymocytes	NULL
;	NULL
T	NULL
cell	NULL
hybridomas	NULL
lost	NULL
AHR	NULL
expression	NULL
during	NULL
prolonged	NULL
cultivation	NULL
.	NULL

We	NULL
observed	NULL
that	NULL
this	NULL
distal	NULL
IL-2	NULL
promoter	NULL
region	NULL
induced	NULL
expression	NULL
of	NULL
luciferase	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
TCDD	NULL
.	NULL

The	NULL
induction	NULL
of	NULL
transcription	NULL
increased	NULL
~13	NULL
times	NULL
compared	NULL
with	NULL
the	NULL
background	NULL
.	NULL

In	NULL
com-parison	NULL
,	NULL
transcription	NULL
from	NULL
pGudlue	NULL
1.1	NULL
(	NULL
29	NULL
)	NULL
,	NULL
which	NULL
contains	NULL
five	NULL
DREs	NULL
from	NULL
CYPIAI	NULL
,	NULL
a	NULL
gene	NULL
highly	NULL
sensitive	NULL
to	NULL
TCDD	NULL
,	NULL
was	NULL
induced	NULL
~20-fold	NULL
(	NULL
Fig	NULL
.	NULL

24	NULL
)	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
obtained	NULL
when	NULL
using	NULL
vectors	NULL
containing	NULL
either	NULL
an	NULL
SV40	NULL
or	NULL
:	NULL
minimal	NULL
promoter	NULL
.	NULL

These	NULL
vectors	NULL
yielded	NULL
different	NULL
backgrounds	NULL
,	NULL
yet	NULL
always	NULL
easily	NULL
detectable	NULL
TCDD	NULL
induced	NULL
luciferase	NULL
expression	NULL
(	NULL
Fig	NULL
.	NULL

2C	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
far	NULL
distal	NULL
region	NULL
of	NULL
the	NULL
IL-2	NULL
promoter	NULL
contains	NULL
DNA	NULL
sequences	NULL
highly	NULL
responsive	NULL
to	NULL
TCDD	NULL
.	NULL

We	NULL
then	NULL
introduced	NULL
single	NULL
point	NULL
mutations	NULL
into	NULL
the	NULL
core	NULL
recognition	NULL
sites	NULL
of	NULL
the	NULL
DREs	NULL
II	NULL
and	NULL
III	NULL
in	NULL
the	NULL
pMMTV-IL-2-DRE	NULL
(	NULL
O.5	NULL
)	NULL
plasmid	NULL
,	NULL
transfected	NULL
cells	NULL
,	NULL
and	NULL
measured	NULL
luciferase	NULL
activity	NULL
.	NULL

When	NULL
both	NULL
DRE	NULL
II	NULL
and	NULL
III	NULL
sites	NULL
are	NULL
mutated	NULL
the	NULL
luciferase	NULL
induction	NULL
by	NULL
TCDD	NULL
is	NULL
abrogated	NULL
.	NULL

A	NULL
mutation	NULL
in	NULL
the	NULL
DRE	NULL
III	NULL
only	NULL
reduced	NULL
the	NULL
response	NULL
but	NULL
did	NULL
not	NULL
completely	NULL
abrogate	NULL
it	NULL
(	NULL
Fig	NULL
.	NULL

24	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
DREs	NULL
are	NULL
necessary	NULL
elements	NULL
and	NULL
both	NULL
elements	NULL
are	NULL
required	NULL
for	NULL
a	NULL
full	NULL
response	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

There	NULL
is	NULL
no	NULL
other	NULL
,	NULL
hidden	NULL
AHR-responsive	NULL
element	NULL
in	NULL
the	NULL
500-bp	NULL
distal	NULL
enhancer	NULL
segment	NULL
.	NULL

However	NULL
,	NULL
as	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
the	NULL
distal	NULL
IL-2	NULL
promoter	NULL
region	NULL
has	NULL
possible	NULL
AP-1	NULL
binding	NULL
sites	NULL
,	NULL
but	NULL
they	NULL
have	NULL
not	NULL
been	NULL
demonstrated	NULL
to	NULL
be	NULL
used	NULL
for	NULL
the	NULL
IL-2	NULL
enhancer/promoter	NULL
.	NULL

It	NULL
is	NULL
known	NULL
that	NULL
the	NULL
liganded	NULL
AHR	NULL
may	NULL
induce	NULL
c-jun	NULL
and	NULL
c-fos	NULL
,	NULL
creating	NULL
AP-1	NULL
(	NULL
30	NULL
)	NULL
.	NULL

To	NULL
supply	NULL
further	NULL
evidence	NULL
that	NULL
DREs	NULL
are	NULL
responsible	NULL
for	NULL
the	NULL
IL-2	NULL
induction	NULL
,	NULL
we	NULL
cloned	NULL
each	NULL
of	NULL
the	NULL
three	NULL
DREs	NULL
separately	NULL
into	NULL
the	NULL
pGudlue	NULL
vector	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
,	NULL
and	NULL
tested	NULL
them	NULL
for	NULL
promoter	NULL
activity	NULL
by	NULL
TCDD	NULL
in	NULL
HepG2	NULL
cells	NULL
.	NULL

The	NULL
results	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2B	NULL
demonstrate	NULL
that	NULL
each	NULL
of	NULL
the	NULL
three	NULL
isolated	NULL
ZL-2-DREs	NULL
can	NULL
drive	NULL
luciferase	NULL
transcription	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
TCDD	NULL
,	NULL
demonstrating	NULL
the	NULL
tran-scription-enhancing	NULL
capacity	NULL
of	NULL
these	NULL
small	NULL
DNA	NULL
elements	NULL
.	NULL

The	NULL
same	NULL
results	NULL
were	NULL
obtained	NULL
with	NULL
pSV-IL-2DRE	NULL
(	NULL
O.1	NULL
)	NULL
in	NULL
which	NULL
the	NULL
putative	NULL
AP-1	NULL
sites	NULL
between	NULL
DRE	NULL
I	NULL
and	NULL
DRE	NULL
II	NULL
are	NULL
deleted	NULL
(	NULL
Fig	NULL
.	NULL

2C	NULL
,	NULL
Table	NULL
IV	NULL
)	NULL
.	NULL

Again	NULL
,	NULL
DRE	NULL
I	NULL
exhibits	NULL
a	NULL
distinctly	NULL
weaker	NULL
response	NULL
,	NULL
which	NULL
agrees	NULL
with	NULL
the	NULL
results	NULL
obtained	NULL
from	NULL
the	NULL
gel	NULL
shift	NULL
assay	NULL
.	NULL

Thus	NULL
,	NULL
at	NULL
least	NULL
DRE	NULL
II	NULL
and	NULL
III	NULL
do	NULL
not	NULL
need	NULL
the	NULL
context	NULL
of	NULL
other	NULL
sequences	NULL
of	NULL
the	NULL
IL-2	NULL
distal	NULL
region	NULL
to	NULL
be	NULL
functional	NULL
as	NULL
promoter	NULL
elements	NULL
.	NULL

To	NULL
verify	NULL
that	NULL
the	NULL
induction	NULL
is	NULL
AHR	NULL
dependent	NULL
,	NULL
we	NULL
performed	NULL
the	NULL
same	NULL
assay	NULL
in	NULL
AHR-	NULL
or	NULL
ARNT-deficient	NULL
cell	NULL
lines	NULL
Hepa	NULL
C12	NULL
and	NULL
Hepa	NULL
C4	NULL
,	NULL
and	NULL
wild-type	NULL
Hepa	NULL
C1	NULL
.	NULL

The	NULL
results	NULL
shown	NULL
in	NULL
Table	NULL
IV	NULL
demonstrate	NULL
that	NULL
functional	NULL
AHR	NULL
as	NULL
well	NULL
as	NULL
ARNT	NULL
are	NULL
necessary	NULL
for	NULL
induction	NULL
driven	NULL
by	NULL
ZL-2-DREs	NULL
.	NULL

Also	NULL
,	NULL
in	NULL
AHR-deficient	NULL
mice	NULL
,	NULL
IL-2	NULL
was	NULL
not	NULL
induced	NULL
by	NULL
TCDD	NULL
(	NULL
see	NULL
below	NULL
)	NULL
.	NULL

Induction	NULL
of	NULL
IL-2	NULL
mRNA	NULL
by	NULL
TCDD	NULL
depends	NULL
on	NULL
the	NULL
differentiation	NULL
stage	NULL
of	NULL
T	NULL
cells	NULL
Most	NULL
eukaryotic	NULL
promoters	NULL
have	NULL
various	NULL
modules	NULL
that	NULL
cooperate	NULL
adaptively	NULL
to	NULL
generate	NULL
differentiation-	NULL
and	NULL
situation-specific	NULL
responses	NULL
.	NULL

Consequently	NULL
,	NULL
modules	NULL
that	NULL
are	NULL
inducible	NULL
in	NULL
in	NULL
vitro	NULL
assays	NULL
could	NULL
be	NULL
not	NULL
accessible	NULL
or	NULL
not	NULL
relevant	NULL
in	NULL
vivo	NULL
.	NULL

Therefore	NULL
,	NULL
we	NULL
tested	NULL
induction	NULL
of	NULL
IL-2	NULL
by	NULL
TCDD	NULL
in	NULL
several	NULL
maturational	NULL
stages	NULL
of	NULL
6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
6978	NULL
IL-2	NULL
DISTAL	NULL
PROMOTER	NULL
ELEMENTS	NULL
REGULATED	NULL
BY	NULL
AH	NULL
RECEPTOR	NULL
Table	NULL
III	NULL
.	NULL

Sequence	NULL
of	NULL
pIL-2	NULL
DREs	NULL
I	NULL
,	NULL
II	NULL
,	NULL
and	NULL
III	NULL
DRE	NULL
I	NULL
5'-GATCACTCCATCACGCAGCCAGTGAGATCCTCCATCACGCAGCCAGTGA-3	NULL
'	NULL
3'-TGAGGTAGTGCGTCGGTCACTCTAGGAGGTAGTGCéTCGGTCACTCTAG-5	NULL
'	NULL
DRE	NULL
II	NULL
5'-GATCATATACACACGCACATAAACAGATCTATACACACGCACATAAACA-3	NULL
'	NULL
3'-TATATGTGTGCGTGTATTTGTCTAGATATGTGTGCéTGTATTTIGTCTAG-S5	NULL
'	NULL
DRE	NULL
IH	NULL
5'-GATCACATGTGCACGCACATGCACAGATCCATGTGCACGCACATGCACA-3	NULL
'	NULL
3'-TGTACACGTGCGTGTACGTGTCTAGGTACACGTGCeTGTACGTGTCTAG-5	NULL
'	NULL
T	NULL
cells	NULL
and	NULL
in	NULL
response	NULL
to	NULL
stimulation	NULL
of	NULL
the	NULL
TCR	NULL
.	NULL

All	NULL
cells	NULL
described	NULL
here	NULL
could	NULL
respond	NULL
to	NULL
TCDD	NULL
with	NULL
CYPIAI	NULL
induction	NULL
,	NULL
which	NULL
indicates	NULL
a	NULL
functional	NULL
AHR/ARNT	NULL
system	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

In	NULL
a	NULL
first	NULL
series	NULL
of	NULL
experiments	NULL
,	NULL
mice	NULL
were	NULL
injected	NULL
with	NULL
50	NULL
pg	NULL
TCDD	NULL
,	NULL
and	NULL
their	NULL
thymocytes	NULL
were	NULL
analyzed	NULL
3	NULL
,	NULL
6	NULL
,	NULL
or	NULL
8	NULL
days	NULL
later	NULL
by	NULL
RT-PCR	NULL
.	NULL

We	NULL
observed	NULL
an	NULL
IL-2	NULL
mRNA	NULL
induction	NULL
in	NULL
vivo	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
DREs	NULL
in	NULL
the	NULL
IL-2	NULL
promoter	NULL
can	NULL
be	NULL
addressed	NULL
(	NULL
Fig	NULL
.	NULL

44	NULL
)	NULL
.	NULL

To	NULL
assess	NULL
whether	NULL
IL-2	NULL
induction	NULL
is	NULL
dependent	NULL
on	NULL
the	NULL
differentiation	NULL
stage	NULL
of	NULL
cells	NULL
,	NULL
we	NULL
next	NULL
set	NULL
up	NULL
fetal	NULL
thymus	NULL
organ	NULL
cultures	NULL
(	NULL
FTOC	NULL
's	NULL
)	NULL
.	NULL

Fetal	NULL
thymi	NULL
were	NULL
excised	NULL
and	NULL
exposed	NULL
to	NULL
TCDD	NULL
for	NULL
4	NULL
or	NULL
5	NULL
days	NULL
.	NULL

Thymocytes	NULL
were	NULL
isolated	NULL
and	NULL
sorted	NULL
to	NULL
high	NULL
purity	NULL
by	NULL
CD4/CD8	NULL
expression	NULL
for	NULL
very	NULL
immature	NULL
(	NULL
CD4	NULL
CD8	NULL
)	NULL
,	NULL
immature	NULL
(	NULL
CD4	NULL
*	NULL
)	NULL
,	NULL
prospective	NULL
helper	NULL
T	NULL
cells	NULL
(	NULL
CD4	NULL
*CD8~	NULL
)	NULL
,	NULL
and	NULL
prospective	NULL
cytotoxic	NULL
T	NULL
cells	NULL
(	NULL
CD4~-CD8	NULL
*	NULL
)	NULL
.	NULL

IL-2	NULL
mRNA	NULL
induction	NULL
was	NULL
measured	NULL
by	NULL
RT-PCR	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

4B	NULL
,	NULL
TCDD	NULL
increased	NULL
IL-2	NULL
mRNA	NULL
in	NULL
total	NULL
thymocytes	NULL
,	NULL
confirming	NULL
previously	NULL
published	NULL
results	NULL
(	NULL
15	NULL
)	NULL
.	NULL

The	NULL
overall	NULL
increase	NULL
was	NULL
attributable	NULL
to	NULL
the	NULL
immature	NULL
CD4	NULL
cells	NULL
and	NULL
future	NULL
cytotoxic	NULL
*	NULL
cells	NULL
,	NULL
both	NULL
of	NULL
which	NULL
responded	NULL
to	NULL
TCDD	NULL
exposure	NULL
with	NULL
a	NULL
strong	NULL
(	NULL
~3-	NULL
and	NULL
5-fold	NULL
)	NULL
increase	NULL
of	NULL
IL-2	NULL
mRNA	NULL
.	NULL

CD4	NULL
~CD8~	NULL
cells	NULL
displayed	NULL
a	NULL
constitutive	NULL
expression	NULL
of	NULL
IL-2	NULL
.	NULL

However	NULL
,	NULL
they	NULL
also	NULL
increased	NULL
IL-2	NULL
mRNA	NULL
by	NULL
TCDD	NULL
.	NULL

CD4*CD8*	NULL
thymocytes	NULL
,	NULL
which	NULL
constitute	NULL
the	NULL
majority	NULL
of	NULL
thymocytes	NULL
,	NULL
remained	NULL
refractory	NULL
to	NULL
TCDD	NULL
.	NULL

Moreover	NULL
,	NULL
A	NULL
IL-2	NULL
induction	NULL
by	NULL
TCDD	NULL
could	NULL
not	NULL
be	NULL
detected	NULL
in	NULL
spleen	NULL
cells	NULL
,	NULL
a	NULL
source	NULL
of	NULL
naive	NULL
,	NULL
fully	NULL
mature	NULL
T	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
IL-2	NULL
induction	NULL
by	NULL
TCDD	NULL
is	NULL
dependent	NULL
on	NULL
the	NULL
maturation	NULL
stage	NULL
of	NULL
thy-mocytes/T	NULL
cells	NULL
,	NULL
and	NULL
the	NULL
responsiveness	NULL
of	NULL
the	NULL
promoter	NULL
can	NULL
be	NULL
switched	NULL
on	NULL
and	NULL
off	NULL
during	NULL
maturation	NULL
of	NULL
T	NULL
cells	NULL
.	NULL

TCDD	NULL
is	NULL
not	NULL
sufficient	NULL
for	NULL
IL-2	NULL
induction	NULL
in	NULL
spleen	NULL
cells	NULL
but	NULL
can	NULL
be	NULL
complemented	NULL
by	NULL
anti-CD3€	NULL
signaling	NULL
Induction	NULL
of	NULL
IL-2	NULL
in	NULL
T	NULL
cells	NULL
classically	NULL
requires	NULL
two	NULL
signals	NULL
,	NULL
one	NULL
from	NULL
the	NULL
TCR	NULL
,	NULL
and	NULL
another	NULL
from	NULL
the	NULL
surface	NULL
receptor	NULL
CD28	NULL
.	NULL

Their	NULL
dual	NULL
triggering	NULL
leads	NULL
to	NULL
a	NULL
cascade	NULL
of	NULL
events	NULL
,	NULL
eventually	NULL
generating	NULL
and	NULL
activating	NULL
components	NULL
like	NULL
c-jun	NULL
and	NULL
c-fos	NULL
complex	NULL
(	NULL
AP-1	NULL
)	NULL
,	NULL
NFAT	NULL
,	NULL
and	NULL
NF-KB	NULL
,	NULL
which	NULL
transactivate	NULL
the	NULL
promoter	NULL
(	NULL
2	NULL
)	NULL
.	NULL

Because	NULL
TCDD	NULL
alone	NULL
was	NULL
not	NULL
sufficient	NULL
to	NULL
induce	NULL
IL-2	NULL
production	NULL
in	NULL
mature	NULL
splenic	NULL
T	NULL
cells	NULL
,	NULL
we	NULL
stimulated	NULL
thymus	NULL
and	NULL
spleen	NULL
cells	NULL
in	NULL
six-well	NULL
plates	NULL
with	NULL
anti-CD3¢e	NULL
Ab	NULL
,	NULL
mimicking	NULL
TCR	NULL
triggering	NULL
.	NULL

Like	NULL
spleen	NULL
cells	NULL
from	NULL
in	NULL
vivo	NULL
exposed	NULL
mice	NULL
,	NULL
spleen	NULL
cells	NULL
exposed	NULL
in	NULL
vitro	NULL
could	NULL
not	NULL
be	NULL
induced	NULL
by	NULL
TCDD	NULL
alone	NULL
(	NULL
Fig	NULL
.	NULL

54	NULL
)	NULL
.	NULL

IL-2	NULL
mRNA	NULL
became	NULL
inducible	NULL
by	NULL
TCDD	NULL
in	NULL
spleen	NULL
cells	NULL
only	NULL
upon	NULL
cross-linking	NULL
with	NULL
anti-CD3e	NULL
Ab	NULL
.	NULL

Induction	NULL
was	NULL
consistently	NULL
about	NULL
4	NULL
times	NULL
over	NULL
the	NULL
untreated	NULL
controls	NULL
,	NULL
but	NULL
there	NULL
was	NULL
a	NULL
threshold	NULL
of	NULL
100	NULL
ng	NULL
of	NULL
anti-CD3e	NULL
necessary	NULL
for	NULL
the	NULL
stimulation	NULL
.	NULL

The	NULL
induction	NULL
of	NULL
IL-2	NULL
mRNA	NULL
was	NULL
readily	NULL
detectable	NULL
within	NULL
4	NULL
h	NULL
,	NULL
i.e	NULL
.	NULL

,	NULL
no	NULL
cell	NULL
division	NULL
was	NULL
DREs	NULL
<	NULL
d	NULL
{	NULL
free	NULL
DREs	NULL
DRE	NULL
1	NULL
(	NULL
1261	NULL
)	NULL
DRE	NULL
II	NULL
(	NULL
-851	NULL
)	NULL
DRE	NULL
III	NULL
(	NULL
-815	NULL
)	NULL
FIGURE	NULL
1	NULL
.	NULL

Detection	NULL
of	NULL
binding	NULL
activity	NULL
of	NULL
the	NULL
AHR/ARNT-complex	NULL
to	NULL
ZL-2-DREs	NULL
.	NULL

ET	NULL
were	NULL
treated	NULL
with	NULL
10	NULL
nM	NULL
TCDD	NULL
or	NULL
0.1	NULL
%	NULL
1,4-dioxan	NULL
as	NULL
a	NULL
solvent	NULL
control	NULL
for	NULL
1	NULL
h.	NULL
Nuclear	NULL
extracts	NULL
(	NULL
A	NULL
)	NULL
and	NULL
cytoplasm	NULL
extracts	NULL
(	NULL
B	NULL
)	NULL
were	NULL
prepared	NULL
,	NULL
and	NULL
EMSA	NULL
with	NULL
radioactive	NULL
labeled	NULL
IL-2-DRE	NULL
I	NULL
,	NULL
II	NULL
,	NULL
and	NULL
III	NULL
were	NULL
performed	NULL
.	NULL

A	NULL
,	NULL
Lanes	NULL
:	NULL
1	NULL
,	NULL
solvent	NULL
control	NULL
;	NULL
2-7	NULL
,	NULL
TCDD	NULL
treatment	NULL
;	NULL
3	NULL
,	NULL
competition	NULL
with	NULL
200-fold	NULL
excess	NULL
of	NULL
unlabeled	NULL
DRE	NULL
from	NULL
the	NULL
murine	NULL
promoter	NULL
;	NULL
4	NULL
,	NULL
competition	NULL
with	NULL
human	NULL
DRE12	NULL
;	NULL
5	NULL
,	NULL
competition	NULL
with	NULL
NS-4	NULL
,	NULL
as	NULL
a	NULL
nonspecific	NULL
competitor	NULL
;	NULL
6-7	NULL
,	NULL
supershift	NULL
with	NULL
anti-AHR	NULL
.	NULL

The	NULL
upper	NULL
arrow	NULL
indicates	NULL
a	NULL
supershift	NULL
of	NULL
the	NULL
AHR/ARNT/DRE	NULL
complex	NULL
by	NULL
the	NULL
anti-AHR	NULL
Ab	NULL
,	NULL
the	NULL
middle	NULL
arrow	NULL
indicates	NULL
the	NULL
AHR/ARNT/DRE	NULL
complex	NULL
,	NULL
and	NULL
the	NULL
lower	NULL
arrow	NULL
indicates	NULL
free	NULL
DREs	NULL
.	NULL

a	NULL
,	NULL
b	NULL
,	NULL
and	NULL
c	NULL
indicate	NULL
unspecific	NULL
binding	NULL
.	NULL

C	NULL
,	NULL
solvent	NULL
control	NULL
;	NULL
T	NULL
,	NULL
10	NULL
nM	NULL
TCDD	NULL
.	NULL

6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
A	NULL
mmiv	NULL
f	NULL
Tuc	NULL
|	NULL
[	NULL
im	NULL
|-	NULL
1	NULL
}	NULL
-	NULL
[	NULL
i	NULL
Hi	NULL
TV	NULL
P	NULL
Luc	NULL
|	NULL
[	NULL
MM	NULL
]	NULL
s	NULL
cypia1	NULL
DRes	NULL
[	NULL
TV	NULL
|	NULL
Luc	NULL
]	NULL
1.	NULL
pControl	NULL
2.	NULL
pMMTV-IL-2DRE	NULL
(	NULL
O.5	NULL
)	NULL
3.	NULL
pGudluc1.1	NULL
4.	NULL
pMMTV-IL-ZDRE	NULL
(	NULL
0.5	NULL
)	NULL
MutII/III	NULL
5.	NULL
pMMTV-IL-2DRE	NULL
(	NULL
O.5	NULL
)	NULL
Mutill	NULL
oa	NULL
8	NULL
i-	NULL
20	NULL
:	NULL
>	NULL
2	NULL
``	NULL
S	NULL
15	NULL
3	NULL
10	NULL
C	NULL
&	NULL
u	NULL
5	NULL
o	NULL
L	NULL
0	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
pDRE	NULL
I	NULL
[	NULL
mH	NULL
T	NULL
[	NULL
T|	NULL
pDRE	NULL
!	NULL

I	NULL
[	NULL
MM	NULL
pH	NULL
pi	NULL
f	NULL
TV	NULL
|	NULL
Euc	NULL
|	NULL
pDRE	NULL
iII	NULL
[	NULL
MM	NULL
Hin	NULL
frr	NULL
f	NULL
TV	NULL
§	NULL
Cuc	NULL
A	NULL
10	NULL
0	NULL
l.—	NULL
3	NULL
7.5	NULL
[	NULL
=d	NULL
.6	NULL
8	NULL
5.0	NULL
C	NULL
£	NULL
u	NULL
2.5	NULL
cl	NULL
LL	NULL
o	NULL
pDRE	NULL
I	NULL
_	NULL
pDREIl	NULL
_	NULL
pDRE	NULL
iI	NULL
1.	NULL
pGL3P	NULL
Bvag	NULL
tue	NULL
2.	NULL
pSVIL-2DRE	NULL
(	NULL
0.5	NULL
)	NULL
(	NULL
|-	NULL
Hm	NULL
]	NULL
3.	NULL
pSVIL-2DRE	NULL
(	NULL
O.1	NULL
)	NULL
-	NULL
[	NULL
FMT	NULL
HMHEvaq	NULL
Tuc	NULL
]	NULL
4.	NULL
pTK	NULL
[	NULL
tk	NULL
|	NULL
Cuc	NULL
]	NULL
5.	NULL
pTKIL-2DRE	NULL
(	NULL
O.5	NULL
)	NULL
IK	NULL
[	NULL
Tus	NULL
]	NULL
Fold	NULL
induction	NULL
by	NULL
TCDD	NULL
a	NULL
-	NULL
s	NULL
a	NULL
3	NULL
o	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
FIGURE	NULL
2	NULL
.	NULL

-	NULL
Functional	NULL
analysis	NULL
of	NULL
DREs	NULL
in	NULL
the	NULL
IL-2	NULL
distal	NULL
region	NULL
.	NULL

A	NULL
and	NULL
B	NULL
,	NULL
Schematic	NULL
representation	NULL
of	NULL
the	NULL
reporter	NULL
gene	NULL
constructs	NULL
with	NULL
the	NULL
MMTV	NULL
promoter	NULL
that	NULL
contain	NULL
the	NULL
-1296	NULL
to	NULL
-756	NULL
fragment	NULL
of	NULL
the	NULL
upstream	NULL
IL-2	NULL
region	NULL
DRE	NULL
motifs	NULL
(	NULL
pMMTV-IL-2der	NULL
(	NULL
0.5	NULL
)	NULL
)	NULL
and	NULL
mutants	NULL
thereof	NULL
(	NULL
single	NULL
base	NULL
exchange	NULL
in	NULL
the	NULL
core	NULL
motif	NULL
indicated	NULL
by	NULL
asterisk	NULL
)	NULL
,	NULL
five	NULL
CypIAI-DRE	NULL
motifs	NULL
(	NULL
pGudlue	NULL
1.1	NULL
)	NULL
,	NULL
two	NULL
copies	NULL
of	NULL
each	NULL
IL-2-DRE	NULL
motif	NULL
(	NULL
pDRE	NULL
I	NULL
,	NULL
II	NULL
,	NULL
or	NULL
III	NULL
)	NULL
between	NULL
the	NULL
MMTV	NULL
promoter	NULL
,	NULL
or	NULL
control	NULL
vector	NULL
(	NULL
pGud-luc1.0	NULL
)	NULL
,	NULL
respectively	NULL
.	NULL

C	NULL
,	NULL
Schematic	NULL
representation	NULL
of	NULL
the	NULL
reporter	NULL
gene	NULL
constructs	NULL
with	NULL
the	NULL
SV40	NULL
or	NULL
ik	NULL
promoter	NULL
that	NULL
contain	NULL
the	NULL
-1296	NULL
to	NULL
-756	NULL
fragment	NULL
of	NULL
the	NULL
upstream	NULL
IL-2	NULL
region	NULL
DRE	NULL
motifs	NULL
.	NULL

HepG2	NULL
cells	NULL
were	NULL
transiently	NULL
transfected	NULL
with	NULL
reporter	NULL
gene	NULL
constructs	NULL
and	NULL
cultured	NULL
with	NULL
the	NULL
solvent	NULL
0.1	NULL
%	NULL
1.4-dioxan	NULL
or	NULL
10	NULL
nM	NULL
TCDD	NULL
.	NULL

Relative	NULL
luciferase	NULL
activities	NULL
(	NULL
lu-ciferase	NULL
activity/ug	NULL
protein	NULL
)	NULL
were	NULL
measured	NULL
by	NULL
luminometer	NULL
14-16	NULL
h	NULL
after	NULL
6979	NULL
AHR/ARNT	NULL
5	NULL
T	NULL
6	NULL
;	NULL
a	NULL
.	NULL

<	NULL
<	NULL
~1261	NULL
-851	NULL
-815	NULL
B	NULL
1300	NULL
1100	NULL
«	NULL
200	NULL
«	NULL
700	NULL
«	NULL
350	NULL
200	NULL
400	NULL
.	NULL

+4	NULL
bp	NULL
FIGURE	NULL
3	NULL
.	NULL

-	NULL
Schematic	NULL
representation	NULL
of	NULL
distal	NULL
and	NULL
proximal	NULL
regions	NULL
in	NULL
the	NULL
mouse	NULL
ZL-2	NULL
promoter	NULL
.	NULL

Functional	NULL
DNA	NULL
motifs	NULL
in	NULL
the	NULL
proximal	NULL
-300	NULL
region	NULL
are	NULL
taken	NULL
from	NULL
the	NULL
literature	NULL
(	NULL
1	NULL
,	NULL
2	NULL
)	NULL
.	NULL

They	NULL
constitute	NULL
the	NULL
minimal	NULL
promoter	NULL
for	NULL
signaling	NULL
by	NULL
TCR/CD3	NULL
and	NULL
CD28	NULL
(	NULL
straight	NULL
line	NULL
)	NULL
.	NULL

Possible	NULL
AP-1	NULL
sites	NULL
in	NULL
the	NULL
distal	NULL
,	NULL
AHR/ARNT-targeted	NULL
region	NULL
(	NULL
dotted	NULL
line	NULL
)	NULL
were	NULL
identified	NULL
by	NULL
computer	NULL
search	NULL
(	NULL
http	NULL
:	NULL
//genomatix.gsf.de/cgi-bin/matinspec-tor/matinspector.pl	NULL
)	NULL
.	NULL

DREs	NULL
are	NULL
according	NULL
to	NULL
Refs	NULL
.	NULL

11	NULL
,	NULL
14	NULL
.	NULL

A	NULL
and	NULL
B	NULL
,	NULL
Regions	NULL
reported	NULL
by	NULL
Novak	NULL
et	NULL
al	NULL
.	NULL

(	NULL
see	NULL
Ref	NULL
.	NULL

2	NULL
)	NULL
to	NULL
have	NULL
positive	NULL
(	NULL
4	NULL
)	NULL
or	NULL
negative	NULL
(	NULL
B	NULL
)	NULL
regulatory	NULL
functions	NULL
on	NULL
IL-2	NULL
promoter	NULL
activity	NULL
.	NULL

necessary	NULL
.	NULL

Also	NULL
,	NULL
in	NULL
thymocytes	NULL
,	NULL
where	NULL
IL-2	NULL
mRNA	NULL
had	NULL
been	NULL
induced	NULL
by	NULL
TCDD	NULL
alone	NULL
in	NULL
vivo	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
,	NULL
additional	NULL
signaling	NULL
via	NULL
the	NULL
TCR	NULL
augmented	NULL
IL-2	NULL
mRNA	NULL
in	NULL
vitro	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
)	NULL
.	NULL

To	NULL
address	NULL
whether	NULL
IL-2	NULL
mRNA	NULL
induction	NULL
leads	NULL
to	NULL
protein	NULL
syn-thesis	NULL
,	NULL
we	NULL
analyzed	NULL
supernatants	NULL
from	NULL
anti-CD3e-stimulated	NULL
cultures	NULL
by	NULL
ELISA	NULL
for	NULL
IL-2	NULL
protein	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

Exposure	NULL
of	NULL
the	NULL
cells	NULL
to	NULL
TCDD	NULL
increased	NULL
IL-2	NULL
protein	NULL
synthesis	NULL
compared	NULL
with	NULL
the	NULL
solvent	NULL
controls	NULL
,	NULL
but	NULL
a	NULL
higher	NULL
concentration	NULL
of	NULL
anti-CD3e	NULL
costimulation	NULL
than	NULL
for	NULL
mRNA	NULL
induction	NULL
was	NULL
needed	NULL
to	NULL
detect	NULL
this	NULL
.	NULL

The	NULL
IL-2	NULL
protein	NULL
production	NULL
lagged	NULL
several	NULL
hours	NULL
compared	NULL
with	NULL
IL-2	NULL
mRNA	NULL
induction	NULL
,	NULL
suggesting	NULL
new	NULL
protein	NULL
synthesis	NULL
.	NULL

At	NULL
least	NULL
for	NULL
spleen	NULL
cells	NULL
,	NULL
cell	NULL
density	NULL
during	NULL
stimulation	NULL
and	NULL
age	NULL
of	NULL
mice	NULL
seemed	NULL
to	NULL
be	NULL
important	NULL
parameters	NULL
for	NULL
the	NULL
strength	NULL
of	NULL
the	NULL
response	NULL
,	NULL
as	NULL
IL-2	NULL
induction	NULL
varied	NULL
depending	NULL
on	NULL
culture	NULL
conditions	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
Ah	NULL
receptor	NULL
is	NULL
necessary	NULL
for	NULL
IL-2	NULL
induction	NULL
by	NULL
TCDD	NULL
in	NULL
vivo	NULL
The	NULL
reporter	NULL
assays	NULL
described	NULL
above	NULL
strongly	NULL
suggested	NULL
that	NULL
the	NULL
IL-2	NULL
promoter	NULL
is	NULL
activated	NULL
via	NULL
the	NULL
TCDD-liganded	NULL
AHR	NULL
at	NULL
its	NULL
distal	NULL
DREs	NULL
.	NULL

To	NULL
rule	NULL
out	NULL
a	NULL
gene-inducing	NULL
mechanism	NULL
of	NULL
TCDD	NULL
not	NULL
involving	NULL
the	NULL
AHR	NULL
,	NULL
we	NULL
injected	NULL
AHR-deficient	NULL
mice	NULL
with	NULL
50	NULL
pg	NULL
TCDD/kg	NULL
body	NULL
weight	NULL
.	NULL

After	NULL
6	NULL
days	NULL
,	NULL
thymus	NULL
cells	NULL
were	NULL
harvested	NULL
and	NULL
total	NULL
RNA	NULL
was	NULL
isolated	NULL
.	NULL

IL-2	NULL
mRNA	NULL
was	NULL
measured	NULL
by	NULL
RT-PCR	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

7	NULL
,	NULL
IL-2	NULL
mRNA	NULL
induction	NULL
by	NULL
TCDD	NULL
is	NULL
detected	NULL
in	NULL
thymus	NULL
cells	NULL
from	NULL
AkR*'*	NULL
and	NULL
AkR*~	NULL
but	NULL
not	NULL
in	NULL
thymus	NULL
cells	NULL
from	NULL
AkR	NULL
'~	NULL
mice	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
IL-2	NULL
mRNA	NULL
induction	NULL
by	NULL
TCDD	NULL
is	NULL
mediated	NULL
by	NULL
the	NULL
Ah	NULL
receptor	NULL
.	NULL

Discussion	NULL
In	NULL
this	NULL
paper	NULL
we	NULL
present	NULL
evidence	NULL
for	NULL
functional	NULL
DNA	NULL
motifs	NULL
in	NULL
the	NULL
distant	NULL
IL-2	NULL
promoter	NULL
,	NULL
which	NULL
confer	NULL
inducibility	NULL
by	NULL
the	NULL
liganded	NULL
AHR	NULL
in	NULL
mouse	NULL
T	NULL
lineage	NULL
cells	NULL
.	NULL

As	NULL
ligand	NULL
we	NULL
used	NULL
TCDD	NULL
,	NULL
which	NULL
is	NULL
considered	NULL
to	NULL
be	NULL
one	NULL
of	NULL
the	NULL
most	NULL
potent	NULL
man-made	NULL
toxic	NULL
sub-stances	NULL
.	NULL

The	NULL
AHR	NULL
mediates	NULL
acute	NULL
and	NULL
chronic	NULL
biological	NULL
effects	NULL
of	NULL
TCDD	NULL
,	NULL
including	NULL
immunosuppression	NULL
and	NULL
changes	NULL
in	NULL
T	NULL
cell	NULL
development	NULL
.	NULL

However	NULL
,	NULL
the	NULL
mechanisms	NULL
for	NULL
AHR-mediated	NULL
pathological	NULL
responses	NULL
are	NULL
not	NULL
well	NULL
understood	NULL
.	NULL

Targeting	NULL
cytokines	NULL
as	NULL
central	NULL
mediators	NULL
of	NULL
immune	NULL
responses	NULL
could	NULL
be	NULL
one	NULL
such	NULL
mech-anism	NULL
.	NULL

Apart	NULL
from	NULL
these	NULL
toxicological	NULL
considerations	NULL
,	NULL
our	NULL
study	NULL
was	NULL
aimed	NULL
at	NULL
understanding	NULL
the	NULL
role	NULL
of	NULL
the	NULL
AHR	NULL
in	NULL
the	NULL
complex	NULL
treatment	NULL
.	NULL

Fold	NULL
induction	NULL
by	NULL
TCDD	NULL
is	NULL
the	NULL
ratio	NULL
of	NULL
the	NULL
relative	NULL
luciferase	NULL
activities	NULL
in	NULL
TCDD-	NULL
vs	NULL
solvent-treated	NULL
samples	NULL
.	NULL

Results	NULL
are	NULL
expressed	NULL
as	NULL
mean	NULL
+	NULL
SEM	NULL
of	NULL
triplicate	NULL
samples	NULL
.	NULL

Experiments	NULL
were	NULL
independently	NULL
repeated	NULL
two	NULL
to	NULL
six	NULL
times	NULL
.	NULL

A	NULL
representative	NULL
result	NULL
is	NULL
shown	NULL
.	NULL

Luc	NULL
:	NULL
luciferase	NULL
.	NULL

6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
6980	NULL
Table	NULL
IV	NULL
.	NULL

Control	NULL
of	NULL
luciferase	NULL
expression	NULL
by	NULL
IL-2	NULL
distal	NULL
sequences	NULL
containing	NULL
DREs	NULL
pIL-2-DRE	NULL
(	NULL
0.5	NULL
)	NULL
``	NULL
pIL-2-DRE	NULL
(	NULL
0.1	NULL
)	NULL
wtlwi	NULL
``	NULL
C°	NULL
70	NULL
+34	NULL
61	NULL
+7	NULL
T	NULL
110	NULL
+	NULL
18	NULL
``	NULL
109	NULL
+	NULL
16°	NULL
AHR	NULL
deficient	NULL
C	NULL
172	NULL
+	NULL
10	NULL
165	NULL
+	NULL
10	NULL
T	NULL
188	NULL
+	NULL
26	NULL
183	NULL
+	NULL
2	NULL
ARNT	NULL
deficient	NULL
C	NULL
155	NULL
+	NULL
23	NULL
166	NULL
+	NULL
7	NULL
T	NULL
172	NULL
+7	NULL
167	NULL
+	NULL
18	NULL
``	NULL
-756	NULL
to	NULL
-1296	NULL
bp	NULL
of	NULL
distal	NULL
IL-2	NULL
sequence	NULL
,	NULL
or	NULL
same	NULL
sequence	NULL
with	NULL
a	NULL
deletion	NULL
between	NULL
DRE	NULL
I	NULL
and	NULL
DRE	NULL
II	NULL
,	NULL
for	NULL
detailed	NULL
plasmid	NULL
description	NULL
see	NULL
Materials	NULL
and	NULL
Meth-ods	NULL
.	NULL

*	NULL
Wild-type	NULL
(	NULL
wt	NULL
)	NULL
and	NULL
cither	NULL
AHR-	NULL
or	NULL
ARNT-deficient	NULL
Hepa	NULL
cell	NULL
lines	NULL
.	NULL

©	NULL
C	NULL
,	NULL
solvent	NULL
control	NULL
;	NULL
T	NULL
,	NULL
TCDD	NULL
treatment	NULL
of	NULL
cells	NULL
.	NULL

``	NULL
Units	NULL
(	NULL
X1000	NULL
)	NULL
of	NULL
luciferase	NULL
expression	NULL
counted	NULL
in	NULL
luminometer	NULL
.	NULL

®	NULL
Data	NULL
for	NULL
control	NULL
and	NULL
TCDD	NULL
treatment	NULL
groups	NULL
were	NULL
evaluated	NULL
by	NULL
Student	NULL
's	NULL
?	NULL

test	NULL
,	NULL
p	NULL
<	NULL
0.05	NULL
for	NULL
bold	NULL
numbers	NULL
.	NULL

regulation	NULL
of	NULL
the	NULL
IL-2	NULL
gene	NULL
.	NULL

IL-2	NULL
promoter	NULL
activity	NULL
is	NULL
regulated	NULL
by	NULL
a	NULL
number	NULL
of	NULL
elements	NULL
,	NULL
i.e	NULL
.	NULL

,	NULL
Oct-1	NULL
,	NULL
NFAT	NULL
,	NULL
NF-KB	NULL
,	NULL
and	NULL
AP-1	NULL
,	NULL
which	NULL
cooperate	NULL
and	NULL
thus	NULL
confer	NULL
the	NULL
lineage	NULL
specificity	NULL
and	NULL
external	NULL
regulation	NULL
of	NULL
IL-2	NULL
.	NULL

Others	NULL
and	NULL
we	NULL
had	NULL
shown	NULL
that	NULL
IL-2	NULL
expression	NULL
could	NULL
be	NULL
induced	NULL
by	NULL
TCDD	NULL
,	NULL
i.e	NULL
.	NULL

,	NULL
the	NULL
AHR	NULL
(	NULL
15	NULL
,	NULL
31	NULL
,	NULL
32	NULL
)	NULL
.	NULL

Extending	NULL
these	NULL
findings	NULL
,	NULL
our	NULL
analysis	NULL
of	NULL
IL-2	NULL
induction	NULL
in	NULL
subpopulations	NULL
of	NULL
thymocytes	NULL
showed	NULL
that	NULL
TCDD	NULL
can	NULL
induce	NULL
IL-2	NULL
mRNA	NULL
in	NULL
CD4TCD8~	NULL
,	NULL
CD4	NULL
~CD8*	NULL
,	NULL
and	NULL
CD4	NULL
~CD8~	NULL
,	NULL
but	NULL
not	NULL
in	NULL
CD4	NULL
``	NULL
CD8	NULL
*	NULL
cells	NULL
.	NULL

Some	NULL
transcription	NULL
factors	NULL
for	NULL
IL-2	NULL
expression	NULL
,	NULL
Oct-1	NULL
,	NULL
Sp-1	NULL
,	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
and	NULL
cAMP	NULL
response	NULL
element	NULL
binding	NULL
protein	NULL
(	NULL
CREB	NULL
)	NULL
,	NULL
can	NULL
be	NULL
expressed	NULL
or	NULL
induced	NULL
in	NULL
thymocytes	NULL
of	NULL
all	NULL
developmental	NULL
stages	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
two	NULL
essential	NULL
transcription	NULL
factors	NULL
,	NULL
AP-1	NULL
and	NULL
NFAT	NULL
,	NULL
are	NULL
absent	NULL
in	NULL
CD4	NULL
~CD8*	NULL
cells	NULL
.	NULL

IL-2	NULL
is	NULL
shut	NULL
off	NULL
during	NULL
this	NULL
maturational	NULL
phase	NULL
and	NULL
only	NULL
becomes	NULL
accessible	NULL
again	NULL
later	NULL
on	NULL
(	NULL
33	NULL
,	NULL
34	NULL
)	NULL
.	NULL

TCDD	NULL
can	NULL
not	NULL
override	NULL
this	NULL
complete	NULL
inaccessi-bility	NULL
.	NULL

Note	NULL
that	NULL
in	NULL
the	NULL
same	NULL
cells	NULL
,	NULL
CYP1A1	NULL
mRNA	NULL
remained	NULL
inducible	NULL
by	NULL
TCDD	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

A	NULL
day	NULL
3	NULL
day	NULL
6	NULL
day	NULL
8	NULL
=	NULL
=	NULL
4+	NULL
$	NULL
0	NULL
=	NULL
=~	NULL
$	NULL
4	NULL
=	NULL
=	NULL
+	NULL
+	NULL
TCDD	NULL
am	NULL
wae	NULL
ast	NULL
“	NULL
warm-2	NULL
UP	NULL
w	NULL
Ww	NULL
wt	NULL
wha	NULL
)	NULL
<	NULL
HPRT	NULL
12	NULL
(	NULL
-J	NULL
Control	NULL
g	NULL
.|	NULL
MMM	NULL
50	NULL
pg	NULL
TCDD/kg	NULL
bw	NULL
.	NULL

IL-2/HPRT	NULL
day	NULL
3	NULL
day	NULL
6	NULL
day	NULL
8	NULL
FIGURE	NULL
4	NULL
.	NULL

IL-2	NULL
DISTAL	NULL
PROMOTER	NULL
ELEMENTS	NULL
REGULATED	NULL
BY	NULL
AH	NULL
RECEPTOR	NULL
In	NULL
contrast	NULL
to	NULL
thymocytes	NULL
,	NULL
TCDD	NULL
alone	NULL
was	NULL
not	NULL
sufficient	NULL
to	NULL
induce	NULL
IL-2	NULL
in	NULL
naive	NULL
T	NULL
cells	NULL
,	NULL
but	NULL
needed	NULL
stimulation	NULL
via	NULL
the	NULL
TCR	NULL
as	NULL
an	NULL
additional	NULL
signal	NULL
.	NULL

Again	NULL
,	NULL
this	NULL
is	NULL
in	NULL
agreement	NULL
with	NULL
findings	NULL
in	NULL
the	NULL
rat	NULL
,	NULL
where	NULL
TCDD	NULL
could	NULL
increase	NULL
serum	NULL
levels	NULL
of	NULL
IL-2	NULL
only	NULL
after	NULL
synergistic	NULL
injections	NULL
of	NULL
staphylococcus	NULL
enterotoxin	NULL
B	NULL
injections	NULL
(	NULL
31	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
thymus	NULL
,	NULL
most	NULL
spleen	NULL
T	NULL
cells	NULL
are	NULL
resting	NULL
and	NULL
thus	NULL
are	NULL
unable	NULL
to	NULL
express	NULL
IL-2	NULL
.	NULL

Stimulation	NULL
via	NULL
the	NULL
TCR/CD3	NULL
pathway	NULL
alone	NULL
triggers	NULL
the	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
pathways	NULL
(	NULL
Raf-1	NULL
,	NULL
extracellular	NULL
signal-related	NULL
kinase	NULL
)	NULL
.	NULL

Together	NULL
with	NULL
CD28	NULL
costimulation	NULL
,	NULL
different	NULL
pathways	NULL
are	NULL
activated	NULL
and	NULL
the	NULL
signal	NULL
cascades	NULL
merge	NULL
and	NULL
eventually	NULL
lead	NULL
to	NULL
AP-1	NULL
formation	NULL
and	NULL
IL-2	NULL
expression	NULL
(	NULL
35	NULL
)	NULL
.	NULL

Activation	NULL
of	NULL
the	NULL
AHR	NULL
can	NULL
bypass	NULL
the	NULL
need	NULL
for	NULL
CD28	NULL
cosignaling	NULL
,	NULL
probably	NULL
in	NULL
that	NULL
an	NULL
alternative	NULL
signal	NULL
transduc-tion	NULL
pathway	NULL
downstream	NULL
of	NULL
the	NULL
TCR/CD3	NULL
is	NULL
used	NULL
.	NULL

Apart	NULL
from	NULL
the	NULL
direct	NULL
transcriptional	NULL
activation	NULL
shown	NULL
here	NULL
,	NULL
other	NULL
possibilities	NULL
of	NULL
the	NULL
AHR	NULL
to	NULL
interfere	NULL
with	NULL
the	NULL
``	NULL
normal	NULL
``	NULL
cell	NULL
signaling	NULL
exist	NULL
.	NULL

A	NULL
recent	NULL
study	NULL
by	NULL
Tian	NULL
et	NULL
al	NULL
.	NULL

(	NULL
36	NULL
)	NULL
demonstrated	NULL
physical	NULL
interaction	NULL
of	NULL
the	NULL
AHR	NULL
with	NULL
NF-KB	NULL
,	NULL
leading	NULL
to	NULL
mutual	NULL
repression	NULL
in	NULL
their	NULL
system	NULL
.	NULL

Upon	NULL
exposure	NULL
to	NULL
TCDD	NULL
,	NULL
c-jun	NULL
,	NULL
c-fos	NULL
,	NULL
and	NULL
c-Jun	NULL
N-ter-minal	NULL
kinase	NULL
induction	NULL
has	NULL
been	NULL
observed	NULL
in	NULL
hepatoma	NULL
cell	NULL
lines	NULL
(	NULL
37	NULL
,	NULL
30	NULL
)	NULL
and	NULL
in	NULL
Jurkat	NULL
cells	NULL
(	NULL
38	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
indirect	NULL
up-regulation	NULL
of	NULL
IL-2	NULL
by	NULL
TCDD	NULL
via	NULL
these	NULL
factors	NULL
is	NULL
possible	NULL
.	NULL

However	NULL
,	NULL
we	NULL
found	NULL
that	NULL
in	NULL
thymocytes	NULL
c-jun	NULL
is	NULL
not	NULL
inducible	NULL
by	NULL
TCDD	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
favoring	NULL
the	NULL
direct	NULL
transcriptional	NULL
activation	NULL
of	NULL
IL-2	NULL
in	NULL
these	NULL
cells	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
AHR	NULL
is	NULL
not	NULL
a	NULL
strong	NULL
transcription	NULL
factor	NULL
in	NULL
itself	NULL
,	NULL
but	NULL
rather	NULL
a	NULL
modulator	NULL
that	NULL
may	NULL
need	NULL
the	NULL
correct	NULL
cellular	NULL
set-up	NULL
for	NULL
its	NULL
function	NULL
.	NULL

Although	NULL
it	NULL
can	NULL
act	NULL
in	NULL
thymocytes	NULL
without	NULL
coactivation	NULL
,	NULL
in	NULL
peripheral	NULL
T	NULL
cells	NULL
it	NULL
needed	NULL
additional	NULL
stimuli	NULL
,	NULL
i.e	NULL
.	NULL

,	NULL
TCR/CD3	NULL
triggering	NULL
.	NULL

It	NULL
is	NULL
interesting	NULL
to	NULL
note	NULL
that	NULL
the	NULL
AHR	NULL
is	NULL
particularly	NULL
abundant	NULL
in	NULL
thymus	NULL
epithelium	NULL
and	NULL
thymocytes	NULL
(	NULL
39	NULL
)	NULL
,	NULL
pointing	NULL
to	NULL
a	NULL
physiological	NULL
role	NULL
in	NULL
this	NULL
tissue	NULL
.	NULL

Also	NULL
,	NULL
the	NULL
fact	NULL
that	NULL
TCDD	NULL
did	NULL
not	NULL
induce	NULL
IL-2	NULL
mRNA	NULL
in	NULL
AHR-deficient	NULL
mice	NULL
clearly	NULL
demonstrated	NULL
that	NULL
the	NULL
AHR	NULL
mediated	NULL
this	NULL
effect	NULL
.	NULL

B	NULL
total	NULL
-	NULL
DN	NULL
_	NULL
DP	NULL
CD8+	NULL
CD4+	NULL
to	NULL
k	NULL
=o	NULL
40	NULL
=	NULL
4+	NULL
=	NULL
4	NULL
o=	NULL
+	NULL
TCDD	NULL
sut	NULL
wand	NULL
some	NULL
C006	NULL
|	NULL
<	NULL
IL-2	NULL
tad	NULL
td	NULL
bus	NULL
bas	NULL
<	NULL
»	NULL
tad	NULL
tat	NULL
tat	NULL
aas	NULL
wt	NULL
|	NULL
<	NULL
HPRT	NULL
12	NULL
[	NULL
-J	NULL
Control	NULL
p-	NULL
9	NULL
-|	NULL
_	NULL
mmm	NULL
10	NULL
nM	NULL
TCDD	NULL
te	NULL
A.	NULL
be	NULL
w	NULL
a	NULL
=	NULL
DN	NULL
DP	NULL
total	NULL
CD8+	NULL
CD4+	NULL
IL-2	NULL
mRNA	NULL
induction	NULL
by	NULL
TCDD	NULL
in	NULL
fetal	NULL
thymocyte	NULL
subpopulations	NULL
and	NULL
in	NULL
adult	NULL
thymus	NULL
cells	NULL
.	NULL

A	NULL
,	NULL
C57BL/6	NULL
mice	NULL
were	NULL
injected	NULL
i.p	NULL
.	NULL

with	NULL
50	NULL
ug	NULL
TCDD/kg	NULL
body	NULL
weight	NULL
or	NULL
corn	NULL
oil	NULL
as	NULL
solvent	NULL
control	NULL
.	NULL

At	NULL
the	NULL
indicated	NULL
days	NULL
,	NULL
IL-2	NULL
and	NULL
HPRT	NULL
mRNA	NULL
from	NULL
adult	NULL
thymus	NULL
cells	NULL
was	NULL
measured	NULL
by	NULL
RT-PCR	NULL
(	NULL
n	NULL
=	NULL
2/day/treatment	NULL
)	NULL
.	NULL

B	NULL
,	NULL
Fetal	NULL
thymus	NULL
lobes	NULL
of	NULL
gestation	NULL
day	NULL
15	NULL
were	NULL
cultured	NULL
in	NULL
FTOC	NULL
for	NULL
4	NULL
or	NULL
5	NULL
days	NULL
with	NULL
solvent	NULL
(	NULL
0.1	NULL
%	NULL
1	NULL
,	NULL
4-dioxan	NULL
)	NULL
or	NULL
10	NULL
nM	NULL
TCDD	NULL
.	NULL

CD4~CD8~	NULL
(	NULL
DN	NULL
)	NULL
,	NULL
CD4*CD8*	NULL
(	NULL
DP	NULL
)	NULL
,	NULL
CD4*CD8~	NULL
(	NULL
CD4*	NULL
)	NULL
,	NULL
and	NULL
CD4~CD8*	NULL
(	NULL
CD8*	NULL
)	NULL
were	NULL
sorted	NULL
by	NULL
FACS	NULL
.	NULL

IL-2	NULL
and	NULL
HPRT	NULL
expression	NULL
in	NULL
total	NULL
thymi	NULL
(	NULL
FTOC	NULL
for	NULL
4	NULL
days	NULL
data	NULL
)	NULL
and	NULL
in	NULL
sorted	NULL
subpopulations	NULL
(	NULL
FTOC	NULL
for	NULL
5	NULL
days	NULL
data	NULL
)	NULL
were	NULL
measured	NULL
by	NULL
RT-PCR	NULL
.	NULL

Amplified	NULL
mRNA	NULL
of	NULL
IL-2	NULL
and	NULL
HPRT	NULL
are	NULL
indicated	NULL
by	NULL
arrows	NULL
.	NULL

Shown	NULL
are	NULL
autoradiographs	NULL
and	NULL
the	NULL
calculated	NULL
densitometric	NULL
indices	NULL
of	NULL
IL-2	NULL
vs	NULL
HPRT	NULL
.	NULL

6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
A	NULL
0	NULL
1000	NULL
500	NULL
250	NULL
100	NULL
50	NULL
[	NULL
anti-CD3	NULL
]	NULL
=o	NULL
o	NULL
$	NULL
-	NULL
#	NULL
4	NULL
-o	NULL
#	NULL
-	NULL
+	NULL
-	NULL
+	NULL
-	NULL
+	NULL
TCDD	NULL
T=	NULL
w	NULL
tad	NULL
#	NULL
06	NULL
--	NULL
tung	NULL
=-	NULL
rans	NULL
io	NULL
wnat	NULL
=	NULL
**	NULL
|	NULL
4	NULL
IL-2	NULL
NF	NULL
nas	NULL
tent	NULL
wae	NULL
RT	NULL
Numb	NULL
tad	NULL
Sum	NULL
bau	NULL
rams	NULL
uk	NULL
+4	NULL
6+	NULL
<	NULL
%	NULL
HP	NULL
4	NULL
L	NULL
--	NULL
Control	NULL
Emam	NULL
10	NULL
nM	NULL
TCDD	NULL
E	NULL
3	NULL
#	NULL
>	NULL
a	NULL
=q	NULL
.	NULL

o	NULL
0	NULL
1000	NULL
500	NULL
250	NULL
100	NULL
-	NULL
50	NULL
[	NULL
anti-CD3	NULL
]	NULL
FIGURE	NULL
5	NULL
.	NULL

IL-2/HPRT	NULL
6981	NULL
B	NULL
0	NULL
1000	NULL
500	NULL
250	NULL
100	NULL
-	NULL
50	NULL
[	NULL
anti-CD3	NULL
]	NULL
#	NULL
oot	NULL
-	NULL
4	NULL
-o	NULL
$	NULL
o	NULL
o	NULL
40-	NULL
o	NULL
4	NULL
=-	NULL
+	NULL
TCDD	NULL
Seed	NULL
Wits	NULL
~-	NULL
>	NULL
Wth	NULL
--	NULL
Ses	NULL
<	NULL
41L-2	NULL
loud	NULL
tind	NULL
bast	NULL
hast	NULL
hunk	NULL
kut	NULL
hint	NULL
kerk	NULL
Tout	NULL
wi	NULL
**	NULL
|	NULL
«	NULL
dc	NULL
HPRT	NULL
4	NULL
(	NULL
-	NULL
]	NULL
Control	NULL
3	NULL
-|	NULL
-	NULL
memmm	NULL
10	NULL
nM	NULL
TCDD	NULL
2	NULL
4	NULL
~	NULL
0	NULL
1000	NULL
500	NULL
250	NULL
100	NULL
50	NULL
[	NULL
anti-CD3	NULL
]	NULL
IL-2	NULL
mRNA	NULL
induction	NULL
by	NULL
TCDD	NULL
in	NULL
anti-CD3e	NULL
Ab-stimulated	NULL
thymus	NULL
cells	NULL
and	NULL
spleen	NULL
cells	NULL
.	NULL

Spleen	NULL
cells	NULL
(	NULL
0.7	NULL
X	NULL
10	NULL
``	NULL
)	NULL
(	NULL
4	NULL
)	NULL
and	NULL
1.0	NULL
X	NULL
10	NULL
``	NULL
thymus	NULL
cells	NULL
(	NULL
B	NULL
)	NULL
from	NULL
6-	NULL
to	NULL
8-wk-old	NULL
C57BL6	NULL
mice	NULL
were	NULL
cultured	NULL
with	NULL
10	NULL
nM	NULL
TCDD	NULL
or	NULL
with	NULL
0.1	NULL
%	NULL
1,4-dioxan	NULL
together	NULL
with	NULL
the	NULL
indicated	NULL
concentrations	NULL
of	NULL
anti-CD3e	NULL
Ab	NULL
.	NULL

After	NULL
4	NULL
h	NULL
,	NULL
total	NULL
RNA	NULL
was	NULL
isolated	NULL
,	NULL
and	NULL
IL-2	NULL
mRNA	NULL
and	NULL
HPRT	NULL
were	NULL
measured	NULL
by	NULL
RT-PCR	NULL
.	NULL

Shown	NULL
are	NULL
autoradiographs	NULL
and	NULL
the	NULL
calculated	NULL
densitometric	NULL
indices	NULL
of	NULL
IL-2	NULL
vs	NULL
HPRT	NULL
.	NULL

DNA	NULL
motifs	NULL
,	NULL
which	NULL
are	NULL
targets	NULL
for	NULL
the	NULL
AHR/ARNT	NULL
complex	NULL
,	NULL
have	NULL
been	NULL
early	NULL
identified	NULL
,	NULL
and	NULL
a	NULL
consensus	NULL
sequence	NULL
was	NULL
inferred	NULL
from	NULL
a	NULL
number	NULL
of	NULL
DREs	NULL
in	NULL
different	NULL
genes	NULL
and	NULL
species	NULL
.	NULL

A	NULL
core	NULL
sequence	NULL
within	NULL
the	NULL
consensus	NULL
sequence	NULL
,	NULL
which	NULL
is	NULL
indispensable	NULL
for	NULL
AHR/ARNT	NULL
contact	NULL
,	NULL
has	NULL
been	NULL
mapped	NULL
(	NULL
14	NULL
)	NULL
.	NULL

The	NULL
DREs	NULL
,	NULL
which	NULL
we	NULL
identified	NULL
in	NULL
the	NULL
upstream	NULL
IL-2	NULL
region	NULL
by	NULL
computer	NULL
analysis	NULL
,	NULL
were	NULL
functionally	NULL
tested	NULL
with	NULL
EMSA	NULL
and	NULL
a	NULL
luciferase	NULL
reporter	NULL
gene	NULL
assay	NULL
.	NULL

Band	NULL
shift	NULL
analysis	NULL
showed	NULL
that	NULL
the	NULL
TCDD-activated	NULL
AHR	NULL
binds	NULL
to	NULL
DRE	NULL
II	NULL
and	NULL
III	NULL
,	NULL
and	NULL
only	NULL
very	NULL
weakly	NULL
to	NULL
DRE	NULL
I	NULL
.	NULL

Likewise	NULL
,	NULL
in	NULL
the	NULL
transfection	NULL
assay	NULL
,	NULL
luciferase	NULL
induction	NULL
was	NULL
higher	NULL
with	NULL
DRE	NULL
II	NULL
and	NULL
DRE	NULL
III	NULL
than	NULL
with	NULL
DRE	NULL
I	NULL
.	NULL

Most	NULL
likely	NULL
this	NULL
reflects	NULL
the	NULL
similarity	NULL
to	NULL
the	NULL
consensus	NULL
sequence	NULL
.	NULL

DRE	NULL
I	NULL
differs	NULL
from	NULL
this	NULL
functional	NULL
consensus	NULL
sequence	NULL
in	NULL
three	NULL
base	NULL
pairs	NULL
,	NULL
whereas	NULL
DRE	NULL
II	NULL
and	NULL
III	NULL
have	NULL
only	NULL
two	NULL
base	NULL
pair	NULL
deviations	NULL
.	NULL

Moreover	NULL
,	NULL
DRE	NULL
II	NULL
and	NULL
III	NULL
have	NULL
bidirectional	NULL
core	NULL
sequences	NULL
,	NULL
which	NULL
are	NULL
reportedly	NULL
particularly	NULL
responsive	NULL
to	NULL
TCDD	NULL
(	NULL
14	NULL
)	NULL
.	NULL

It	NULL
is	NULL
less	NULL
likely	NULL
that	NULL
the	NULL
broader	NULL
context	NULL
of	NULL
other	NULL
DNA	NULL
sequences	NULL
is	NULL
important	NULL
,	NULL
as	NULL
our	NULL
luciferase	NULL
experiments	NULL
with	NULL
the	NULL
bare	NULL
DRE	NULL
sequences	NULL
imply	NULL
.	NULL

Mutation	NULL
of	NULL
the	NULL
DREs	NULL
abrogated	NULL
the	NULL
response	NULL
,	NULL
demonstrating	NULL
that	NULL
there	NULL
is	NULL
no	NULL
other	NULL
hidden	NULL
DRE	NULL
in	NULL
the	NULL
500-bp	NULL
distal	NULL
region	NULL
we	NULL
analyzed	NULL
.	NULL

Also	NULL
,	NULL
both	NULL
DRE	NULL
II	NULL
and	NULL
III	NULL
are	NULL
needed	NULL
for	NULL
a	NULL
full	NULL
response	NULL
.	NULL

Even	NULL
mutating	NULL
just	NULL
one	NULL
of	NULL
them	NULL
stopped	NULL
the	NULL
induction	NULL
of	NULL
the	NULL
reporter	NULL
gene	NULL
;	NULL
only	NULL
a	NULL
small	NULL
rest	NULL
activity	NULL
remained	NULL
.	NULL

Generally	NULL
,	NULL
very	NULL
little	NULL
is	NULL
known	NULL
about	NULL
synergistic	NULL
or	NULL
antagonistic	NULL
effects	NULL
of	NULL
spatial	NULL
distribution	NULL
of	NULL
transcription	NULL
factor	NULL
binding	NULL
elements	NULL
,	NULL
which	NULL
may	NULL
be	NULL
crucial	NULL
in	NULL
promoter	NULL
regulation	NULL
.	NULL

Most	NULL
functionally	NULL
investigated	NULL
DREs	NULL
are	NULL
located	NULL
between	NULL
-1200	NULL
and	NULL
-800	NULL
bp	NULL
in	NULL
the	NULL
upstream	NULL
regions	NULL
of	NULL
the	NULL
CYPIA1	NULL
from	NULL
mice	NULL
,	NULL
rats	NULL
,	NULL
and	NULL
humans	NULL
(	NULL
40-42	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
the	NULL
ZL-2-DREs	NULL
were	NULL
also	NULL
located	NULL
between	NULL
-1200	NULL
and	NULL
-800	NULL
bp	NULL
in	NULL
the	NULL
upstream	NULL
region	NULL
,	NULL
and	NULL
many	NULL
potential	NULL
DREs	NULL
in	NULL
a	NULL
number	NULL
of	NULL
genes	NULL
are	NULL
located	NULL
in	NULL
very	NULL
distal	NULL
positions	NULL
(	NULL
11	NULL
)	NULL
.	NULL

Possibly	NULL
,	NULL
the	NULL
distance	NULL
is	NULL
functionally	NULL
important	NULL
,	NULL
such	NULL
that	NULL
chromatin	NULL
structure	NULL
is	NULL
changed	NULL
and	NULL
serves	NULL
as	NULL
a	NULL
stable	NULL
nucleation	NULL
site	NULL
for	NULL
enhancer-promoter	NULL
communication	NULL
and	NULL
chromatin	NULL
remodeling	NULL
,	NULL
as	NULL
has	NULL
been	NULL
suggested	NULL
for	NULL
other	NULL
genes	NULL
(	NULL
43	NULL
)	NULL
.	NULL

Ward	NULL
and	NULL
colleagues	NULL
have	NULL
analyzed	NULL
this	NULL
by	NULL
mapping	NULL
of	NULL
DNasel	NULL
hypersensitivity	NULL
sites	NULL
for	NULL
the	NULL
IL-2	NULL
promoter	NULL
,	NULL
albeit	NULL
only	NULL
until	NULL
-730	NULL
.	NULL

They	NULL
demonstrated	NULL
the	NULL
importance	NULL
of	NULL
upstream	NULL
regions	NULL
for	NULL
chro-	NULL
matin	NULL
remodeling	NULL
and	NULL
gene	NULL
accessibility	NULL
(	NULL
44	NULL
)	NULL
.	NULL

It	NULL
would	NULL
be	NULL
interesting	NULL
to	NULL
perform	NULL
similar	NULL
studies	NULL
on	NULL
the	NULL
even	NULL
further	NULL
upstream	NULL
region	NULL
and	NULL
to	NULL
analyze	NULL
remodeling	NULL
under	NULL
the	NULL
influence	NULL
of	NULL
the	NULL
AHR/	NULL
ARNT	NULL
complex	NULL
in	NULL
a	NULL
tissue-specific	NULL
setting	NULL
.	NULL

This	NULL
could	NULL
also	NULL
help	NULL
to	NULL
understand	NULL
data	NULL
conceived	NULL
from	NULL
cat	NULL
reporter	NULL
assays	NULL
in	NULL
ELAE1	NULL
cells	NULL
,	NULL
indicating	NULL
a	NULL
negative	NULL
regulatory	NULL
role	NULL
of	NULL
the	NULL
-700	NULL
to	NULL
-1000	NULL
region	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

In	NULL
the	NULL
context	NULL
of	NULL
AHR/ARNT	NULL
activation	NULL
,	NULL
this	NULL
negative	NULL
regulation	NULL
might	NULL
be	NULL
inverted	NULL
.	NULL

Also	NULL
in	NULL
humans	NULL
a	NULL
few	NULL
DRE	NULL
consensus	NULL
sequences	NULL
can	NULL
be	NULL
found	NULL
in	NULL
the	NULL
very	NULL
far	NULL
5	NULL
'	NULL
region	NULL
(	NULL
e.g	NULL
.	NULL

,	NULL
at	NULL
-7324	NULL
,	NULL
-3528	NULL
,	NULL
-3398	NULL
,	NULL
-2735	NULL
,	NULL
-2354	NULL
)	NULL
;	NULL
however	NULL
,	NULL
no	NULL
functional	NULL
data	NULL
are	NULL
available	NULL
.	NULL

The	NULL
human	NULL
and	NULL
mouse	NULL
distal	NULL
IL-2	NULL
promoter	NULL
have	NULL
many	NULL
features	NULL
in	NULL
common	NULL
,	NULL
but	NULL
expression	NULL
levels	NULL
differed	NULL
in	NULL
the	NULL
careful	NULL
analysis	NULL
of	NULL
isolated	NULL
sequences	NULL
in	NULL
chloramphenicol	NULL
acetyltransferase	NULL
(	NULL
CAT	NULL
)	NULL
assays	NULL
done	NULL
by	NULL
Novak	NULL
et	NULL
al	NULL
.	NULL

(	NULL
2	NULL
)	NULL
.	NULL

The	NULL
500-bp	NULL
stretch	NULL
we	NULL
analyzed	NULL
here	NULL
has	NULL
only	NULL
little	NULL
homology	NULL
to	NULL
the	NULL
human	NULL
IL-2	NULL
upstream	NULL
region	NULL
(	NULL
2	NULL
)	NULL
.	NULL

It	NULL
is	NULL
impossible	NULL
to	NULL
say	NULL
at	NULL
this	NULL
time	NULL
whether	NULL
the	NULL
human	NULL
IL-2	NULL
promoter	NULL
would	NULL
also	NULL
be	NULL
responsive	NULL
to	NULL
AHR	NULL
.	NULL

ARNT	NULL
is	NULL
the	NULL
dimerization	NULL
partner	NULL
of	NULL
the	NULL
AHR	NULL
;	NULL
the	NULL
complex	NULL
forms	NULL
in	NULL
the	NULL
nucleus	NULL
,	NULL
and	NULL
both	NULL
proteins	NULL
participate	NULL
in	NULL
DNA	NULL
binding	NULL
400	NULL
T	NULL
s000	NULL
€	NULL
as	NULL
&	NULL
anoo	NULL
a	NULL
&	NULL
&	NULL
200	NULL
%	NULL
s000	NULL
3	NULL
,	NULL
=	NULL
2000	NULL
100	NULL
T	NULL
0	NULL
r	NULL
r	NULL
r	NULL
i	NULL
0	NULL
®	NULL
r	NULL
r	NULL
t	NULL
T	NULL
n	NULL
o	NULL
0	NULL
20	NULL
40	NULL
60	NULL
B	NULL
400	NULL
24	NULL
o	NULL
0	NULL
2	NULL
40	NULL
§	NULL
00	NULL
&	NULL
0	NULL
10	NULL
Incubation	NULL
time	NULL
(	NULL
h	NULL
)	NULL
Incubation	NULL
time	NULL
(	NULL
h	NULL
)	NULL
FIGURE	NULL
6	NULL
.	NULL

IL-2	NULL
protein	NULL
induction	NULL
by	NULL
TCDD	NULL
in	NULL
thymus	NULL
and	NULL
spleen	NULL
cells	NULL
.	NULL

Spleen	NULL
cells	NULL
(	NULL
0.7	NULL
X	NULL
10	NULL
``	NULL
)	NULL
(	NULL
4	NULL
)	NULL
or	NULL
1.0	NULL
X	NULL
10	NULL
``	NULL
thymus	NULL
cells	NULL
(	NULL
B	NULL
)	NULL
were	NULL
cultured	NULL
with	NULL
10	NULL
nM	NULL
TCDD	NULL
(	NULL
closed	NULL
symbols	NULL
)	NULL
or	NULL
0.1	NULL
%	NULL
1,4-dioxan	NULL
as	NULL
solvent	NULL
control	NULL
(	NULL
open	NULL
symbols	NULL
)	NULL
on	NULL
the	NULL
indicated	NULL
concentrations	NULL
of	NULL
the	NULL
anti-CD3e	NULL
Ab-coated	NULL
six-well	NULL
plates	NULL
(	NULL
2	NULL
ug	NULL
RML	NULL
]	NULL
,	NULL
1	NULL
u	NULL
g	NULL
p	NULL
,	NULL
0.5	NULL
ug	NULL
@	NULL
O	NULL
)	NULL
.	NULL

Supernatants	NULL
were	NULL
taken	NULL
after	NULL
4	NULL
,	NULL
6	NULL
,	NULL
8	NULL
,	NULL
10	NULL
,	NULL
and	NULL
24	NULL
h	NULL
,	NULL
and	NULL
IL-2	NULL
protein	NULL
was	NULL
measured	NULL
by	NULL
ELISA	NULL
.	NULL

6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
6982	NULL
IL-2	NULL
DISTAL	NULL
PROMOTER	NULL
ELEMENTS	NULL
REGULATED	NULL
BY	NULL
AH	NULL
RECEPTOR	NULL
Control	NULL
TCDD	NULL
Control	NULL
TCDD	NULL
Control	NULL
TCDD	NULL
I	NULL
Sre	NULL
I	NULL
yea	NULL
--	NULL
]	NULL
iL-2	NULL
fant	NULL
mat	NULL
tas	NULL
tus	NULL
tant	NULL
]	NULL
hast	NULL
tent	NULL
tant	NULL
tart	NULL
<	NULL
riprt	NULL
AhR	NULL
+/+	NULL
AhR	NULL
+/-	NULL
AhR	NULL
/-5	NULL
4	NULL
4	NULL
[	NULL
-	NULL
]	NULL
Control	NULL
C	NULL
ua	NULL
TCDD	NULL
&	NULL
3	NULL
4	NULL
§	NULL
rl	NULL
=	NULL
1	NULL
4	NULL
°	NULL
``	NULL
I	NULL
L	NULL
L	NULL
L	NULL
J	NULL
AnR+/+	NULL
AnR+/-	NULL
AhR-/-	NULL
FIGURE	NULL
7	NULL
.	NULL

-	NULL
IL-2	NULL
is	NULL
not	NULL
induced	NULL
by	NULL
TCDD	NULL
in	NULL
thymus	NULL
cells	NULL
from	NULL
AkR	NULL
'~	NULL
mice	NULL
.	NULL

AkR*'*	NULL
mice	NULL
(	NULL
C57BL6	NULL
)	NULL
and	NULL
AkR	NULL
*~	NULL
and	NULL
AhR	NULL
'~	NULL
from	NULL
inbred	NULL
mice	NULL
(	NULL
B6,129	NULL
AhR	NULL
~	NULL
X	NULL
C57BL6	NULL
AkR*~	NULL
)	NULL
were	NULL
injected	NULL
with	NULL
50	NULL
ug	NULL
TCDD/kg	NULL
body	NULL
weight	NULL
or	NULL
corn	NULL
oil	NULL
as	NULL
solvent	NULL
control	NULL
.	NULL

After	NULL
6	NULL
days	NULL
,	NULL
IL-2	NULL
and	NULL
HPRT	NULL
mRNA	NULL
expressions	NULL
in	NULL
the	NULL
thymus	NULL
were	NULL
measured	NULL
by	NULL
RT-PCR	NULL
.	NULL

Shown	NULL
are	NULL
autoradiographs	NULL
and	NULL
the	NULL
calculated	NULL
densitometric	NULL
indices	NULL
of	NULL
IL-2	NULL
vs	NULL
HPRT	NULL
.	NULL

(	NULL
10	NULL
)	NULL
.	NULL

Our	NULL
data	NULL
are	NULL
consistent	NULL
with	NULL
this	NULL
because	NULL
TCDD	NULL
can	NULL
not	NULL
induce	NULL
IL-2	NULL
expression	NULL
in	NULL
ARNT-deficient	NULL
cell	NULL
lines	NULL
.	NULL

Interestingly	NULL
,	NULL
when	NULL
we	NULL
searched	NULL
for	NULL
a	NULL
suitable	NULL
cell	NULL
line	NULL
for	NULL
the	NULL
transfection	NULL
experiments	NULL
,	NULL
we	NULL
could	NULL
not	NULL
find	NULL
any	NULL
T	NULL
cell	NULL
line	NULL
that	NULL
expresses	NULL
high	NULL
levels	NULL
of	NULL
AHR	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
all	NULL
tested	NULL
T	NULL
cell	NULL
lines	NULL
constitutively	NULL
expressed	NULL
ARNT	NULL
.	NULL

Thymocytes	NULL
and	NULL
thymic	NULL
epithelium	NULL
contained	NULL
AHR	NULL
in	NULL
abundance	NULL
.	NULL

ARNT	NULL
is	NULL
another	NULL
member	NULL
of	NULL
the	NULL
bHLH-PAS	NULL
family	NULL
,	NULL
and	NULL
it	NULL
can	NULL
dimerize	NULL
not	NULL
only	NULL
with	NULL
AHR	NULL
but	NULL
also	NULL
with	NULL
yet	NULL
other	NULL
bHLH-PAS	NULL
proteins	NULL
,	NULL
for	NULL
instance	NULL
,	NULL
hypoxia-inducible	NULL
factor	NULL
1	NULL
a	NULL
(	NULL
HIF-1	NULL
@	NULL
)	NULL
,	NULL
a	NULL
protein	NULL
shown	NULL
to	NULL
be	NULL
involved	NULL
in	NULL
organogenesis	NULL
by	NULL
response	NULL
to	NULL
oxygen	NULL
pressure	NULL
in	NULL
tissues	NULL
.	NULL

Competition	NULL
for	NULL
ARNT	NULL
in	NULL
a	NULL
cell	NULL
may	NULL
be	NULL
another	NULL
control	NULL
mechanism	NULL
for	NULL
transcriptional	NULL
regula-tion	NULL
,	NULL
i.e	NULL
.	NULL

,	NULL
ARNT	NULL
is	NULL
the	NULL
central	NULL
regulator	NULL
in	NULL
this	NULL
protein	NULL
family	NULL
(	NULL
5	NULL
,	NULL
45	NULL
)	NULL
.	NULL

Is	NULL
there	NULL
a	NULL
physiological	NULL
or	NULL
pathological	NULL
relevance	NULL
for	NULL
IL-2	NULL
induction	NULL
by	NULL
TCDD	NULL
?	NULL

TCDD	NULL
causes	NULL
thymus	NULL
atrophy	NULL
and	NULL
immune	NULL
suppression	NULL
at	NULL
low	NULL
doses	NULL
in	NULL
many	NULL
animal	NULL
species	NULL
(	NULL
6-9	NULL
)	NULL
.	NULL

The	NULL
finding	NULL
that	NULL
TCDD	NULL
induces	NULL
IL-2	NULL
production	NULL
seems	NULL
paradoxical	NULL
,	NULL
as	NULL
IL-2	NULL
is	NULL
an	NULL
established	NULL
growth	NULL
and	NULL
survival	NULL
factor	NULL
for	NULL
T	NULL
cells	NULL
.	NULL

However	NULL
,	NULL
more	NULL
recently	NULL
,	NULL
the	NULL
role	NULL
of	NULL
IL-2	NULL
in	NULL
T	NULL
lymphocyte	NULL
death	NULL
has	NULL
been	NULL
discovered	NULL
.	NULL

In	NULL
mice	NULL
genetically	NULL
deficient	NULL
for	NULL
IL-2	NULL
,	NULL
autoreactive	NULL
lymphoid	NULL
cells	NULL
accumulated	NULL
due	NULL
to	NULL
a	NULL
failure	NULL
of	NULL
activation-induced	NULL
cell	NULL
death	NULL
(	NULL
18	NULL
,	NULL
46	NULL
,	NULL
47	NULL
)	NULL
.	NULL

Also	NULL
,	NULL
in	NULL
FTOC	NULL
,	NULL
the	NULL
addition	NULL
of	NULL
exogenous	NULL
IL-2	NULL
inhibited	NULL
proliferation	NULL
and	NULL
differentiation	NULL
of	NULL
T	NULL
cells	NULL
and	NULL
diminished	NULL
total	NULL
cell	NULL
yields	NULL
(	NULL
48-50	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
Fas	NULL
ligand	NULL
mRNA	NULL
in	NULL
CD4~CD8	NULL
*	NULL
thymocytes	NULL
becomes	NULL
up-regulated	NULL
upon	NULL
TCDD	NULL
exposure	NULL
of	NULL
FTOCs	NULL
(	NULL
M.-S.	NULL
Jeon	NULL
,	NULL
unpublished	NULL
observation	NULL
)	NULL
,	NULL
suggesting	NULL
a	NULL
possible	NULL
mechanism	NULL
for	NULL
TCDD-induced	NULL
thymus	NULL
atrophy	NULL
.	NULL

Thus	NULL
,	NULL
it	NULL
can	NULL
not	NULL
be	NULL
excluded	NULL
that	NULL
IL-2	NULL
induction	NULL
by	NULL
TCDD	NULL
may	NULL
be	NULL
causally	NULL
connected	NULL
to	NULL
the	NULL
various	NULL
immunosuppressive	NULL
effects	NULL
of	NULL
this	NULL
toxic	NULL
compound	NULL
,	NULL
although	NULL
it	NULL
needs	NULL
further	NULL
investigation	NULL
.	NULL

Here	NULL
we	NULL
demonstrated	NULL
for	NULL
the	NULL
first	NULL
time	NULL
a	NULL
direct	NULL
interaction	NULL
between	NULL
AHR	NULL
and	NULL
DRE	NULL
in	NULL
the	NULL
promoter	NULL
region	NULL
of	NULL
the	NULL
IL-2	NULL
gene	NULL
,	NULL
which	NULL
is	NULL
an	NULL
important	NULL
gene	NULL
in	NULL
the	NULL
immune	NULL
system	NULL
.	NULL

Whether	NULL
TCDD-induced	NULL
IL-2	NULL
expression	NULL
or	NULL
the	NULL
induction	NULL
of	NULL
other	NULL
genes	NULL
results	NULL
in	NULL
immune	NULL
suppression	NULL
has	NULL
to	NULL
be	NULL
investigated	NULL
in	NULL
further	NULL
studies	NULL
.	NULL

In	NULL
summary	NULL
,	NULL
the	NULL
TCDD-liganded	NULL
AHR	NULL
is	NULL
capable	NULL
of	NULL
inducing	NULL
transcription	NULL
of	NULL
IL-2	NULL
in	NULL
mouse	NULL
thymocytes	NULL
and	NULL
T	NULL
cells	NULL
.	NULL

The	NULL
natural	NULL
ligand	NULL
of	NULL
the	NULL
AHR	NULL
is	NULL
not	NULL
yet	NULL
known	NULL
.	NULL

We	NULL
are	NULL
tempted	NULL
to	NULL
speculate	NULL
that	NULL
the	NULL
natural	NULL
ligand	NULL
is	NULL
a	NULL
player	NULL
in	NULL
IL-2	NULL
induction	NULL
and	NULL
thus	NULL
important	NULL
for	NULL
cell	NULL
homeostasis	NULL
.	NULL

Acknowledgments	NULL
We	NULL
thank	NULL
Michael	NULL
Denison	NULL
(	NULL
University	NULL
of	NULL
California	NULL
at	NULL
Davis	NULL
)	NULL
for	NULL
gifts	NULL
of	NULL
the	NULL
pGudluc	NULL
plasmids	NULL
,	NULL
Roland	NULL
Palacios	NULL
(	NULL
Basel	NULL
Institute	NULL
of	NULL
Immunology	NULL
)	NULL
for	NULL
the	NULL
ET	NULL
cell	NULL
line	NULL
,	NULL
and	NULL
Oliver	NULL
Hankinson	NULL
(	NULL
University	NULL
of	NULL
California	NULL
at	NULL
Los	NULL
Angeles	NULL
)	NULL
for	NULL
the	NULL
gift	NULL
of	NULL
Hepa	NULL
cell	NULL
lines	NULL
.	NULL

At	NULL
our	NULL
own	NULL
institute	NULL
,	NULL
we	NULL
thank	NULL
Josef	NULL
Abel	NULL
and	NULL
Olaf	NULL
Dohr	NULL
for	NULL
advice	NULL
and	NULL
Marianne	NULL
Niermann-Kaiser	NULL
for	NULL
expert	NULL
technical	NULL
help	NULL
.	NULL

We	NULL
are	NULL
grateful	NULL
to	NULL
our	NULL
colleagues	NULL
Ernst	NULL
Gleichmann	NULL
,	NULL
Suzan	NULL
Artik	NULL
,	NULL
Zhi-Wei	NULL
Lai	NULL
,	NULL
and	NULL
to	NULL
Virginia	NULL
Shapiro	NULL
at	NULL
the	NULL
University	NULL
of	NULL
California	NULL
at	NULL
San	NULL
Francisco	NULL
for	NULL
critical	NULL
reading	NULL
of	NULL
the	NULL
manuscript	NULL
.	NULL

References	NULL
1	NULL
.	NULL

Jain	NULL
,	NULL
D.	NULL
,	NULL
C.	NULL
Lob	NULL
,	NULL
and	NULL
A.	NULL
Rao	NULL
.	NULL

1995	NULL
.	NULL

Transcriptional	NULL
regulation	NULL
of	NULL
the	NULL
IL-2	NULL
gene	NULL
.	NULL

Curr	NULL
.	NULL

Opin	NULL
.	NULL

Immunol	NULL
.	NULL

7:333	NULL
.	NULL

2	NULL
.	NULL

Novak	NULL
,	NULL
T.	NULL
J.	NULL
,	NULL
P.	NULL
M.	NULL
White	NULL
,	NULL
and	NULL
E.	NULL
V.	NULL
Rothenberg	NULL
.	NULL

1990	NULL
.	NULL

Regulatory	NULL
anatomy	NULL
of	NULL
the	NULL
murine	NULL
interleukin-2	NULL
gene	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

18:4523	NULL
.	NULL

3	NULL
.	NULL

Ema	NULL
,	NULL
M.	NULL
,	NULL
K.	NULL
Sogawa	NULL
,	NULL
N.	NULL
Watanabe	NULL
,	NULL
Y.	NULL
Chujoh	NULL
,	NULL
N.	NULL
Matsushita	NULL
,	NULL
O.	NULL
Gotoh	NULL
,	NULL
Y.	NULL
Funae	NULL
,	NULL
and	NULL
Y.	NULL
Fujii-Kuriyama	NULL
.	NULL

1992.	NULL
cDNA	NULL
cloning	NULL
and	NULL
structure	NULL
of	NULL
mouse	NULL
putative	NULL
Ah	NULL
receptor	NULL
.	NULL

Biochem	NULL
.	NULL

Biophys	NULL
.	NULL

Res	NULL
.	NULL

Commun	NULL
.	NULL

184:246	NULL
.	NULL

4	NULL
.	NULL

Burbach	NULL
,	NULL
K.	NULL
M.	NULL
,	NULL
A.	NULL
Poland	NULL
,	NULL
and	NULL
C.	NULL
A.	NULL
Bradfield	NULL
.	NULL

1992	NULL
.	NULL

Cloning	NULL
of	NULL
the	NULL
Ah-receptor	NULL
cDNA	NULL
reveals	NULL
a	NULL
distinctive	NULL
ligand-activated	NULL
transcription	NULL
factor	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
89:8185	NULL
.	NULL

5	NULL
.	NULL

Crews	NULL
,	NULL
S.	NULL
T.	NULL
1998	NULL
.	NULL

Control	NULL
of	NULL
cell	NULL
lineage-specific	NULL
development	NULL
and	NULL
transcription	NULL
by	NULL
bHLH-PAS	NULL
proteins	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

12:607	NULL
.	NULL

6	NULL
.	NULL

McConkey	NULL
,	NULL
D.	NULL
J.	NULL
,	NULL
P.	NULL
Hartzell	NULL
,	NULL
S.	NULL
K.	NULL
Duddy	NULL
,	NULL
H.	NULL
Hakansson	NULL
,	NULL
and	NULL
S.	NULL
Orrenius	NULL
.	NULL

1988	NULL
.	NULL

2,3,7,8-Tetrachlorodibenzo-p-dioxin	NULL
kills	NULL
immature	NULL
thymocytes	NULL
by	NULL
Ca**-medi-ated	NULL
endonuclease	NULL
activation	NULL
.	NULL

Science	NULL
242:256	NULL
.	NULL

7	NULL
.	NULL

Rhile	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
M.	NULL
Nagarkatti	NULL
,	NULL
and	NULL
P.	NULL
S.	NULL
Nagarkatti	NULL
.	NULL

1996	NULL
.	NULL

Role	NULL
of	NULL
Fas	NULL
apoptosis	NULL
and	NULL
MHC	NULL
genes	NULL
in	NULL
2,3,7,8-tetrachlorodibenzo-p-dioxin	NULL
(	NULL
TCDD	NULL
)	NULL
-induced	NULL
immuno-toxicity	NULL
of	NULL
T	NULL
cells	NULL
.	NULL

Toxicology	NULL
110:153	NULL
.	NULL

8	NULL
.	NULL

Nebert	NULL
,	NULL
D.	NULL
W.	NULL
,	NULL
A.	NULL
Puga	NULL
,	NULL
and	NULL
V.	NULL
Vasiliou	NULL
.	NULL

1993	NULL
.	NULL

Role	NULL
of	NULL
the	NULL
Ah	NULL
receptor	NULL
and	NULL
dioxin	NULL
inducible	NULL
(	NULL
Ah	NULL
)	NULL
gene	NULL
battery	NULL
in	NULL
toxicity	NULL
,	NULL
cancer	NULL
,	NULL
and	NULL
signal	NULL
transduction	NULL
.	NULL

Ann	NULL
.	NULL

NY	NULL
Acad	NULL
.	NULL

Sci	NULL
.	NULL

685:624	NULL
.	NULL

9	NULL
.	NULL

Huff	NULL
,	NULL
J.	NULL
,	NULL
G.	NULL
Lucier	NULL
,	NULL
and	NULL
A.	NULL
Tritscher	NULL
.	NULL

1994	NULL
.	NULL

Carcinogenicity	NULL
of	NULL
TCDD	NULL
:	NULL
experi-mental	NULL
,	NULL
mechanistic	NULL
,	NULL
and	NULL
epidemiologic	NULL
evidence	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Pharmacol	NULL
.	NULL

Toxicol	NULL
.	NULL

34:343	NULL
.	NULL

10	NULL
.	NULL

Reyes	NULL
,	NULL
H.	NULL
,	NULL
S.	NULL
Reisz-Porszasz	NULL
,	NULL
and	NULL
O.	NULL
Hankinson	NULL
.	NULL

1992	NULL
.	NULL

Identification	NULL
of	NULL
the	NULL
Ah	NULL
receptor	NULL
nuclear	NULL
translocator	NULL
protein	NULL
(	NULL
Arnt	NULL
)	NULL
as	NULL
a	NULL
component	NULL
of	NULL
the	NULL
DNA	NULL
binding	NULL
form	NULL
of	NULL
the	NULL
Ah	NULL
receptor	NULL
.	NULL

Science	NULL
256:1193	NULL
.	NULL

11	NULL
.	NULL

Lai	NULL
,	NULL
Z.-W.	NULL
,	NULL
T.	NULL
Pineau	NULL
,	NULL
and	NULL
C.	NULL
Esser	NULL
.	NULL

1996	NULL
.	NULL

Identification	NULL
of	NULL
dioxin-responsive	NULL
elements	NULL
(	NULL
DREs	NULL
)	NULL
in	NULL
the	NULL
5	NULL
'	NULL
regions	NULL
of	NULL
putative	NULL
dioxin-inducible	NULL
genes	NULL
.	NULL

Chem	NULL
.	NULL

Biol	NULL
.	NULL

Interact	NULL
.	NULL

100:97	NULL
.	NULL

12	NULL
.	NULL

Jones	NULL
,	NULL
P.	NULL
B.	NULL
C.	NULL
,	NULL
L.	NULL
K.	NULL
Durrin	NULL
,	NULL
D.	NULL
R.	NULL
Galeazzi	NULL
,	NULL
and	NULL
J.	NULL
P.	NULL
Whitlock	NULL
,	NULL
Jr.	NULL
1986	NULL
.	NULL

Control	NULL
of	NULL
cytochrome	NULL
P1-450	NULL
gene	NULL
expression	NULL
:	NULL
analysis	NULL
of	NULL
a	NULL
dioxin-responsive	NULL
enhancer	NULL
system	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
83:2802	NULL
.	NULL

13	NULL
.	NULL

Fujisawa-Schara	NULL
,	NULL
A.	NULL
,	NULL
M.	NULL
Yamane	NULL
,	NULL
and	NULL
Y.	NULL
Fujii-Kuriyama	NULL
.	NULL

1988	NULL
.	NULL

A	NULL
DNA-binding	NULL
factor	NULL
specific	NULL
for	NULL
xenobiotic	NULL
responsive	NULL
elements	NULL
of	NULL
P-450	NULL
gene	NULL
exists	NULL
as	NULL
a	NULL
cryptic	NULL
form	NULL
in	NULL
cytoplasm	NULL
:	NULL
its	NULL
possible	NULL
translocation	NULL
to	NULL
nucleus	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
85:5859	NULL
.	NULL

14	NULL
.	NULL

Lusska	NULL
,	NULL
A.	NULL
,	NULL
E.	NULL
Shen	NULL
,	NULL
and	NULL
J.	NULL
P.	NULL
Whitlock	NULL
,	NULL
Jr.	NULL
1993	NULL
.	NULL

Protein-DNA	NULL
interactions	NULL
at	NULL
a	NULL
dioxin-responsive	NULL
enhancer	NULL
:	NULL
analysis	NULL
of	NULL
six	NULL
bona	NULL
fide	NULL
DNA-binding	NULL
sites	NULL
for	NULL
the	NULL
liganded	NULL
Ah	NULL
receptor	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268:6575	NULL
.	NULL

15	NULL
.	NULL

Lai	NULL
,	NULL
Z-W.	NULL
,	NULL
C.	NULL
Hundeiker	NULL
,	NULL
E.	NULL
Gleichmann	NULL
,	NULL
and	NULL
C.	NULL
Esser	NULL
.	NULL

1997	NULL
.	NULL

Cytokine	NULL
gene	NULL
expression	NULL
during	NULL
ontogeny	NULL
in	NULL
murine	NULL
thymus	NULL
on	NULL
activation	NULL
of	NULL
the	NULL
aryl	NULL
hydrocarbon	NULL
receptor	NULL
by	NULL
2,3,7,8-tetrachlorodibenzo-p-dioxin	NULL
.	NULL

Mol	NULL
.	NULL

Pharmacol	NULL
.	NULL

52:30	NULL
.	NULL

16	NULL
.	NULL

Gaido	NULL
,	NULL
K.	NULL
W.	NULL
,	NULL
S.	NULL
C.	NULL
Maness	NULL
,	NULL
L.	NULL
S.	NULL
Leonard	NULL
,	NULL
and	NULL
W.	NULL
F.	NULL
Greenlee	NULL
.	NULL

1992	NULL
.	NULL

2,3,7,8-Terachlorodibenzo-p-dioxin-dependent	NULL
regulation	NULL
of	NULL
transforming	NULL
growth	NULL
fac-tors-a	NULL
and	NULL
-B2	NULL
expression	NULL
in	NULL
a	NULL
human	NULL
keratinocyte	NULL
cell	NULL
line	NULL
involves	NULL
both	NULL
transcriptional	NULL
and	NULL
post-transcriptional	NULL
control	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

267:24591	NULL
.	NULL

17	NULL
.	NULL

Smith	NULL
,	NULL
K.	NULL
A..	NULL
1988	NULL
.	NULL

Interleukin-2	NULL
:	NULL
inception	NULL
,	NULL
impact	NULL
,	NULL
and	NULL
implications	NULL
.	NULL

Science	NULL
240:1169	NULL
.	NULL

18	NULL
.	NULL

Refaeli	NULL
,	NULL
Y.	NULL
,	NULL
L.	NULL
Van	NULL
Parijs	NULL
,	NULL
C.	NULL
A.	NULL
London	NULL
,	NULL
J.	NULL
Tschopp	NULL
,	NULL
and	NULL
A.	NULL
K.	NULL
Abbas	NULL
.	NULL

1998	NULL
.	NULL

Biochemical	NULL
mechanisms	NULL
of	NULL
IL-2-regulated	NULL
Fas-mediated	NULL
T	NULL
cell	NULL
apoptosis	NULL
.	NULL

Immunity	NULL
8:615	NULL
.	NULL

19	NULL
.	NULL

Juhlin	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
G.	NULL
V.	NULL
Alm	NULL
.	NULL

1976	NULL
.	NULL

Morphologic	NULL
and	NULL
antigenic	NULL
maturation	NULL
of	NULL
lym-phocytes	NULL
in	NULL
the	NULL
mouse	NULL
thymus	NULL
in	NULL
vitro	NULL
.	NULL

Scand	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

5:497	NULL
.	NULL

20	NULL
.	NULL

Kisiclow	NULL
,	NULL
P.	NULL
1990	NULL
.	NULL

Applications	NULL
of	NULL
fetal	NULL
thymus	NULL
organ	NULL
cultures	NULL
in	NULL
studies	NULL
of	NULL
T	NULL
cell	NULL
development	NULL
.	NULL

In	NULL
Immunological	NULL
Methods	NULL
,	NULL
Vol	NULL
IV	NULL
.	NULL

I.	NULL
Lefkovits	NULL
and	NULL
B.	NULL
Pernis	NULL
,	NULL
eds	NULL
.	NULL

Academic	NULL
Press	NULL
,	NULL
San	NULL
Diego	NULL
,	NULL
p.	NULL
291	NULL
.	NULL

21	NULL
.	NULL

Kremer	NULL
,	NULL
J.	NULL
,	NULL
E.	NULL
Gleichmann	NULL
,	NULL
and	NULL
C.	NULL
Esser	NULL
.	NULL

1994	NULL
.	NULL

Thymic	NULL
stroma	NULL
exposed	NULL
to	NULL
arylhydrocarbon	NULL
receptor-binding	NULL
xenobiotic	NULL
fails	NULL
to	NULL
support	NULL
proliferation	NULL
of	NULL
early	NULL
thymocytes	NULL
but	NULL
induces	NULL
differentiation	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

153:2778	NULL
.	NULL

22	NULL
.	NULL

Melton	NULL
,	NULL
D.	NULL
W.	NULL
,	NULL
D.	NULL
S.	NULL
Konecki	NULL
,	NULL
J.	NULL
Brennand	NULL
,	NULL
and	NULL
C.	NULL
T.	NULL
Caskey	NULL
.	NULL

1984	NULL
.	NULL

Structure	NULL
,	NULL
expression	NULL
,	NULL
and	NULL
mutation	NULL
of	NULL
the	NULL
hypoxanthine	NULL
phosphoribosyItransferase	NULL
gene	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
81:2147	NULL
.	NULL

23	NULL
.	NULL

Wong	NULL
,	NULL
H.	NULL
,	NULL
W.	NULL
D.	NULL
Anderson	NULL
,	NULL
T.	NULL
Cheng	NULL
,	NULL
and	NULL
K.	NULL
T.	NULL
Raibowol	NULL
.	NULL

1994	NULL
.	NULL

Monitoring	NULL
mRNA	NULL
expression	NULL
by	NULL
polymerase	NULL
chain	NULL
reaction	NULL
:	NULL
the	NULL
``	NULL
primer-dropping	NULL
``	NULL
method	NULL
.	NULL

Anal	NULL
.	NULL

Biochem	NULL
.	NULL

223:251	NULL
.	NULL

24	NULL
.	NULL

Palacios	NULL
,	NULL
R.	NULL
,	NULL
S.	NULL
Studer	NULL
,	NULL
J.	NULL
Samaridis	NULL
,	NULL
and	NULL
J.	NULL
Pelkonen	NULL
.	NULL

1989	NULL
.	NULL

Thymic	NULL
epithelial	NULL
cells	NULL
induce	NULL
in	NULL
vitro	NULL
differentiation	NULL
of	NULL
PRO-T	NULL
lymphocyte	NULL
clones	NULL
into	NULL
TCR	NULL
a	NULL
,	NULL
B/T3®	NULL
and	NULL
TCR	NULL
y	NULL
,	NULL
8/T3*	NULL
cells	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

8:4053	NULL
.	NULL

25	NULL
.	NULL

Whitlock	NULL
,	NULL
P.	NULL
J.	NULL
Jr.	NULL
,	NULL
and	NULL
D.	NULL
R.	NULL
Galeazzi	NULL
.	NULL

1984	NULL
.	NULL

2,3,7,8-Tetrachlorodibenzo-p-dixon	NULL
receptors	NULL
in	NULL
wild	NULL
type	NULL
and	NULL
variant	NULL
mouse	NULL
hepatoma	NULL
cells	NULL
:	NULL
nuclear	NULL
location	NULL
and	NULL
strength	NULL
of	NULL
nuclear	NULL
binding	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

259:980	NULL
.	NULL

26	NULL
.	NULL

Saatcioglu	NULL
,	NULL
F.	NULL
,	NULL
D.	NULL
J.	NULL
Perry	NULL
,	NULL
D.	NULL
S.	NULL
Pasco	NULL
,	NULL
and	NULL
J	NULL
.	NULL

B.	NULL
Fagan	NULL
.	NULL

1990	NULL
.	NULL

Aryl	NULL
hydrocarbon	NULL
(	NULL
Ab	NULL
)	NULL
receptor	NULL
DNA-binding	NULL
activity	NULL
:	NULL
sequence	NULL
specificity	NULL
and	NULL
Zn**	NULL
requirement	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

265:9251	NULL
.	NULL

27	NULL
.	NULL

Thomsen	NULL
,	NULL
J.	NULL
S.	NULL
,	NULL
L.	NULL
Nissen	NULL
,	NULL
S.	NULL
N.	NULL
Stacey	NULL
,	NULL
R.	NULL
N.	NULL
Hines	NULL
,	NULL
and	NULL
H.	NULL
Autrup	NULL
.	NULL

1991	NULL
.	NULL

Differences	NULL
in	NULL
2,3,7,8-tetrachlorodibenzo-p-dioxin-inducible	NULL
CYP1A1	NULL
expression	NULL
6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38.	NULL
in	NULL
human	NULL
breast	NULL
carcinoma	NULL
cell	NULL
lines	NULL
involve	NULL
altered	NULL
frans-acting	NULL
factors	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Biochem	NULL
.	NULL

197:577	NULL
.	NULL

Hapgood	NULL
,	NULL
J.	NULL
,	NULL
S.	NULL
Cuthill	NULL
,	NULL
M.	NULL
Denis	NULL
,	NULL
L.	NULL
Poellinger	NULL
,	NULL
and	NULL
J	NULL
.	NULL

A.	NULL
Gustafsson	NULL
.	NULL

1989	NULL
.	NULL

Specific	NULL
protein-DNA	NULL
interactions	NULL
at	NULL
a	NULL
xenobiotic-responsive	NULL
element	NULL
:	NULL
co-purifi-cation	NULL
of	NULL
dioxin	NULL
receptor	NULL
and	NULL
DNA-binding	NULL
activity	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
86:60	NULL
.	NULL

Garrison	NULL
,	NULL
P.	NULL
M.	NULL
,	NULL
K.	NULL
Tullis	NULL
,	NULL
J.	NULL
M.	NULL
M.	NULL
Aarts	NULL
,	NULL
A.	NULL
Brouwer	NULL
,	NULL
J.	NULL
P.	NULL
Giesy	NULL
,	NULL
and	NULL
M.	NULL
S.	NULL
Denison	NULL
.	NULL

1996	NULL
.	NULL

Species-specific	NULL
recombinant	NULL
cell	NULL
lines	NULL
as	NULL
bioassay	NULL
systems	NULL
for	NULL
the	NULL
detection	NULL
of	NULL
2,3,7,8-tetrachlorodibenzo-p-dioxin-like	NULL
chemicals	NULL
.	NULL

Fund	NULL
.	NULL

Appl	NULL
.	NULL

Toxicol	NULL
.	NULL

30:194	NULL
.	NULL

Hoffer	NULL
,	NULL
A.	NULL
,	NULL
C.-Y	NULL
.	NULL

Chang	NULL
,	NULL
and	NULL
A.	NULL
Puga	NULL
.	NULL

1996	NULL
.	NULL

Dioxin	NULL
induces	NULL
transcription	NULL
of	NULL
fos	NULL
and	NULL
jun	NULL
genes	NULL
by	NULL
Ah	NULL
receptor-dependent	NULL
and	NULL
-independent	NULL
pathways	NULL
.	NULL

Toxicol	NULL
.	NULL

Appl	NULL
.	NULL

Pharmacol	NULL
.	NULL

141:238	NULL
.	NULL

Huang	NULL
,	NULL
W.	NULL
,	NULL
and	NULL
L.	NULL
D.	NULL
Koller	NULL
.	NULL

1998	NULL
.	NULL

2,3,7,8-Tetrachlorodibenzo-p-dioxin	NULL
co-stim-ulates	NULL
staphylococcal	NULL
enterotoxin	NULL
B	NULL
(	NULL
SEB	NULL
)	NULL
cytokine	NULL
production	NULL
and	NULL
phenotypic	NULL
cell	NULL
cycling	NULL
in	NULL
Long-Evans	NULL
rats	NULL
.	NULL

Int	NULL
.	NULL

J.	NULL
Immunopharmacol	NULL
.	NULL

20:39	NULL
.	NULL

Kerkvliet	NULL
,	NULL
N.	NULL
L	NULL
,	NULL
L.	NULL
Baccher-Steppan	NULL
,	NULL
D.	NULL
M.	NULL
Shepherd	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Oughton	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
Vorderstrasse	NULL
,	NULL
and	NULL
G.	NULL
K.	NULL
DeKrey	NULL
.	NULL

1996	NULL
.	NULL

Inhibition	NULL
of	NULL
TC-1	NULL
cytokine	NULL
pro-duction	NULL
,	NULL
effector	NULL
cytotoxic	NULL
T	NULL
lymphocyte	NULL
development	NULL
and	NULL
alloantibody	NULL
production	NULL
by	NULL
2,3,7,8-tetrachlorodibenzo-p-dioxin	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

157:2310	NULL
.	NULL

Chen	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
E.	NULL
V.	NULL
Rothenberg	NULL
.	NULL

1993	NULL
.	NULL

Molecular	NULL
basis	NULL
for	NULL
developmental	NULL
changes	NULL
in	NULL
interleukin-2	NULL
gene	NULL
inducibility	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13:228	NULL
.	NULL

Rincon	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
R.	NULL
A.	NULL
Flavell	NULL
.	NULL

1996	NULL
.	NULL

Regulation	NULL
of	NULL
AP-1	NULL
and	NULL
NFAT	NULL
transcription	NULL
factors	NULL
during	NULL
thymic	NULL
selection	NULL
of	NULL
T	NULL
cells	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

16:1074	NULL
.	NULL

Williams	NULL
,	NULL
N.	NULL
1996	NULL
.	NULL

T	NULL
cell	NULL
inactivation	NULL
linked	NULL
to	NULL
Ras	NULL
block	NULL
.	NULL

Science	NULL
271:1234	NULL
.	NULL

Tian	NULL
,	NULL
Y.	NULL
,	NULL
S.	NULL
Ke	NULL
,	NULL
M.	NULL
S.	NULL
Denison	NULL
,	NULL
A	NULL
.	NULL

B.	NULL
Rabson	NULL
,	NULL
and	NULL
M.	NULL
A.	NULL
Gallo	NULL
.	NULL

1999	NULL
.	NULL

Ah	NULL
receptor	NULL
and	NULL
NF-KB	NULL
interactions	NULL
,	NULL
a	NULL
potential	NULL
mechanism	NULL
for	NULL
dioxin	NULL
toxicity	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

274:510	NULL
.	NULL

Puga	NULL
,	NULL
A.	NULL
,	NULL
D.	NULL
W.	NULL
Nebert	NULL
,	NULL
and	NULL
F.	NULL
Carrier	NULL
.	NULL

1992	NULL
.	NULL

Dioxin	NULL
induces	NULL
expression	NULL
of	NULL
c-fos	NULL
and	NULL
c-jun	NULL
proto-oncogenes	NULL
and	NULL
a	NULL
large	NULL
increase	NULL
in	NULL
transcription	NULL
factor	NULL
AP-1	NULL
.	NULL

DNA	NULL
Cell	NULL
Biol	NULL
.	NULL

11:269	NULL
.	NULL

Hossain	NULL
,	NULL
A.	NULL
,	NULL
S.	NULL
Tsuchiya	NULL
,	NULL
M.	NULL
Mincgishi	NULL
,	NULL
M.	NULL
Osada	NULL
,	NULL
S.	NULL
Ikawa	NULL
,	NULL
F.-A	NULL
.	NULL

Tezuka	NULL
,	NULL
M.	NULL
Kaji	NULL
,	NULL
T.	NULL
Konno	NULL
,	NULL
M.	NULL
Watanabe	NULL
,	NULL
and	NULL
H.	NULL
Kikuchi	NULL
.	NULL

1998	NULL
.	NULL

The	NULL
Ah	NULL
receptor	NULL
is	NULL
not	NULL
39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

49	NULL
.	NULL

50	NULL
.	NULL

6983	NULL
involved	NULL
in	NULL
2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated	NULL
apoptosis	NULL
in	NULL
human	NULL
leukemic	NULL
T	NULL
cell	NULL
lines	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

273:19853	NULL
.	NULL

Carlstedt-Duke	NULL
,	NULL
J.	NULL
M.	NULL
1979	NULL
.	NULL

Tissue	NULL
distribution	NULL
of	NULL
the	NULL
receptor	NULL
for	NULL
2,3,7,8-tetrachlorodibenzo-p-dioxin	NULL
in	NULL
the	NULL
rat	NULL
.	NULL

Cancer	NULL
Res	NULL
.	NULL

39:3172	NULL
.	NULL

Denison	NULL
,	NULL
M.	NULL
S.	NULL
,	NULL
J.	NULL
M.	NULL
Fisher	NULL
,	NULL
and	NULL
J.	NULL
P.	NULL
Whitlock	NULL
,	NULL
Jr.	NULL
1989	NULL
.	NULL

Protein-DNA	NULL
interactions	NULL
at	NULL
recognition	NULL
sites	NULL
for	NULL
the	NULL
dioxin-Ah	NULL
receptor	NULL
complex	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

264:16478	NULL
.	NULL

Fujisawa-Schara	NULL
,	NULL
A.	NULL
,	NULL
K.	NULL
Sogawa	NULL
,	NULL
C.	NULL
Nishi	NULL
,	NULL
and	NULL
Y.	NULL
Pujii-Kuriyama	NULL
.	NULL

1986	NULL
.	NULL

Regulatory	NULL
DNA	NULL
elements	NULL
localized	NULL
remotely	NULL
upstream	NULL
from	NULL
the	NULL
drug-metabolizing	NULL
cytochrome	NULL
P-450c	NULL
gene	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

14:1465	NULL
.	NULL

Hines	NULL
,	NULL
R.	NULL
N.	NULL
,	NULL
J.	NULL
M.	NULL
Mathis	NULL
,	NULL
and	NULL
C.	NULL
S.	NULL
Jacob	NULL
.	NULL

1988	NULL
.	NULL

Identification	NULL
of	NULL
multiple	NULL
regulatory	NULL
elements	NULL
on	NULL
the	NULL
human	NULL
cytochrome	NULL
P4501A1	NULL
gene	NULL
.	NULL

Carcinogenesis	NULL
9:1599	NULL
.	NULL

Bagga	NULL
,	NULL
R.	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Armstrong	NULL
,	NULL
and	NULL
B.	NULL
M.	NULL
Emerson	NULL
.	NULL

1998	NULL
.	NULL

Cold	NULL
Spring	NULL
Harbor	NULL
Symp	NULL
.	NULL

Quant	NULL
.	NULL

Biol	NULL
.	NULL

63:569.	NULL
.	NULL

Ward	NULL
,	NULL
S.	NULL
B.	NULL
,	NULL
G.	NULL
Hernandez-Hoyos	NULL
,	NULL
F.	NULL
Chen	NULL
,	NULL
M.	NULL
Waterman	NULL
,	NULL
R.	NULL
Reeves	NULL
,	NULL
and	NULL
E.	NULL
V.	NULL
Rothenberg	NULL
.	NULL

1998	NULL
.	NULL

Chromatin	NULL
remodeling	NULL
of	NULL
the	NULL
interleukin-2	NULL
gene	NULL
:	NULL
distinct	NULL
alterations	NULL
in	NULL
the	NULL
proximal	NULL
versus	NULL
distal	NULL
enhancer	NULL
regions	NULL
.	NULL

Nucleic	NULL
Acid	NULL
Res	NULL
.	NULL

26:2923	NULL
.	NULL

Rowlands	NULL
,	NULL
J.	NULL
C.	NULL
,	NULL
and	NULL
J.-A	NULL
.	NULL

Gustafsson	NULL
.	NULL

1997	NULL
.	NULL

Aryl	NULL
hydrocarbon	NULL
receptor-mediated	NULL
signal	NULL
transduction	NULL
.	NULL

Crif	NULL
.	NULL

Rev	NULL
.	NULL

Toxicol	NULL
.	NULL

27:109	NULL
.	NULL

Theze	NULL
,	NULL
J.	NULL
,	NULL
P.	NULL
M.	NULL
Alzari	NULL
,	NULL
and	NULL
J.	NULL
Bertoglio	NULL
.	NULL

1996	NULL
.	NULL

Interleukin	NULL
2	NULL
and	NULL
its	NULL
receptors	NULL
:	NULL
recent	NULL
advances	NULL
and	NULL
new	NULL
immunological	NULL
functions	NULL
.	NULL

Immunol	NULL
.	NULL

Today	NULL
17:481	NULL
.	NULL

Kneitz	NULL
,	NULL
B.	NULL
,	NULL
T.	NULL
Herrmann	NULL
,	NULL
S.	NULL
Yonehara	NULL
,	NULL
and	NULL
A.	NULL
Schimpl	NULL
.	NULL

1995	NULL
.	NULL

Normal	NULL
clonal	NULL
expansion	NULL
but	NULL
impaired	NULL
Fas-mediated	NULL
cell	NULL
death	NULL
and	NULL
anergy	NULL
induction	NULL
in	NULL
inter-leukin-2-deficient	NULL
mice	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

25:2572	NULL
.	NULL

Skinner	NULL
,	NULL
M.	NULL
,	NULL
G.	NULL
Le	NULL
Gros	NULL
,	NULL
J.	NULL
Marbrook	NULL
,	NULL
and	NULL
J.	NULL
D.	NULL
Watson	NULL
.	NULL

1987	NULL
.	NULL

Development	NULL
of	NULL
fetal	NULL
thymocytes	NULL
in	NULL
organ	NULL
cultures	NULL
:	NULL
effect	NULL
of	NULL
interleukin	NULL
2	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

165:481	NULL
.	NULL

Waanders	NULL
,	NULL
G.	NULL
A.	NULL
,	NULL
and	NULL
R.	NULL
L.	NULL
Boyd	NULL
.	NULL

1990	NULL
.	NULL

The	NULL
effects	NULL
of	NULL
interleukin	NULL
2	NULL
on	NULL
early	NULL
and	NULL
late	NULL
thymocyte	NULL
differentiation	NULL
in	NULL
foetal	NULL
thymus	NULL
organ	NULL
culture	NULL
.	NULL

Int	NULL
.	NULL

Immunol	NULL
.	NULL

2:461	NULL
.	NULL

Waanders	NULL
,	NULL
G.	NULL
A.	NULL
,	NULL
D.	NULL
I.	NULL
Godfrey	NULL
,	NULL
and	NULL
R.	NULL
L.	NULL
Boyd	NULL
.	NULL

1989	NULL
.	NULL

Modulation	NULL
of	NULL
T-cell	NULL
differentiation	NULL
in	NULL
murine	NULL
fetal	NULL
thymus	NULL
organ	NULL
cultures	NULL
.	NULL

Thymus	NULL
13:73	NULL
.	NULL

6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL

